Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-25.60 Insider Own0.30% Shs Outstand327.80M Perf Week2.51%
Market Cap56.03B Forward P/E10.09 EPS next Y16.94 Insider Trans0.00% Shs Float327.17M Perf Month2.90%
Income-8519.10M PEG- EPS next Q4.22 Inst Own89.10% Short Float3.16% Perf Quarter5.47%
Sales15.68B P/S3.57 EPS this Y24.90% Inst Trans-1.18% Short Ratio3.09 Perf Half Y22.06%
Book/sh182.05 P/B0.94 EPS next Y1.24% ROA-8.50% Target Price183.64 Perf Year-6.58%
Cash/sh6.02 P/C28.39 EPS next 5Y3.70% ROE-13.20% 52W Range114.27 - 192.69 Perf YTD27.88%
Dividend2.96 P/FCF12.99 EPS past 5Y-36.00% ROI-4.80% 52W High-11.30% Beta1.64
Dividend %1.73% Quick Ratio0.90 Sales past 5Y43.40% Gross Margin85.10% 52W Low49.58% ATR1.54
Employees16900 Current Ratio1.00 Sales Q/Q-0.80% Oper. Margin-54.60% RSI (14)69.21 Volatility0.85% 0.90%
OptionableYes Debt/Eq0.38 EPS Q/Q-285.10% Profit Margin-54.20% Rel Volume0.53 Prev Close170.92
ShortableYes LT Debt/Eq0.33 EarningsNov 05 BMO Payout- Avg Volume3.35M Price170.92
Recom2.70 SMA202.00% SMA504.35% SMA20013.91% Volume0 Change0.00%
Aug-07-19Downgrade Guggenheim Buy → Neutral
Jul-18-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-16-19Downgrade Bernstein Outperform → Mkt Perform
Jun-11-19Initiated Barclays Underweight $133
May-28-19Initiated Goldman Neutral
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-17-19 07:00AM  Allergan to Report Third Quarter 2019 Financial Results PR Newswire
Oct-16-19 12:16PM  Editas Inks Deal for Gene Editing Neurological Disease Drugs Zacks
12:02PM  'High-level dope dealers': Democratic candidates sound off on big pharma Yahoo Finance
Oct-15-19 05:04PM  Allergan (AGN) Shareholders Approve Acquisition by AbbVie Zacks
Oct-14-19 07:04PM  Johnson & Johnson's (JNJ) Legal Problems Continue to Worry Investors Zacks
10:28AM  Aclaris Divests Rhofade to EPI Health for $55M, Shares Up Zacks
09:15AM  Allergan Shareholders Approve Proposed Acquisition by AbbVie PR Newswire
Oct-11-19 07:40PM  Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration PR Newswire
Oct-10-19 10:11AM  Wet AMD Space in Focus: New Drug Approvals & Key Advancements Zacks
07:30AM  On World Sight Day, Allergan Launches National Campaign to Raise Awareness of the Toll Glaucoma Takes on Everyday Living PR Newswire
Oct-07-19 07:30AM  Allergan Expands REFRESH® Portfolio With New REFRESH® RELIEVA Lubricant Eye Drop Product Line PR Newswire
Oct-03-19 05:30PM  Here Is Hedge Funds 22nd Most Popular Stock Pick Insider Monkey
04:17PM  Here Are 3 Notable Pharma Stocks That Could Top Third-Quarter Estimates Investor's Business Daily
12:14PM  INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of the Following Merger PR Newswire
11:16AM  J&J Settles Ahead of Multi-District Opioid Trial, Stock Up Zacks
09:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
07:30AM  Allergan to Showcase Late-Stage Data in Age-Related Macular Degeneration and Glaucoma at American Academy of Ophthalmology Annual Meeting PR Newswire
Oct-02-19 04:21PM  Pharma Giant J&J Avoids Opioid Trial In Ohio With $20.4 Million Payout Investor's Business Daily
Oct-01-19 05:50PM  Allergan (AGN) Stock Moves -1.09%: What You Should Know Zacks
05:02PM  Opioid makers, distributors face shaky future as legal woes mount Yahoo Finance
Sep-30-19 07:22AM  5 Most Shorted Sectors in 2019 Investopedia
Sep-27-19 05:33PM  IntelGenx (IGXT) Resubmits NDA for Migraine Candidate to FDA Zacks
04:57PM  FTC requests AbbVie, Allergan for more information on $63 billion deal Reuters
04:16PM  Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction PR Newswire
04:15PM  AbbVie and Allergan Receive Second Request from Federal Trade Commission on Pending Transaction PR Newswire
Sep-26-19 01:46PM  Citi Bullish On AbbVie As Allergan Deal Provides An Earnings Floor Benzinga
11:30AM  ALLERGAN MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation into Whether the Sale of Allergan PLC is Fair to Shareholders; Investors are Encouraged to Contact the Firm - AGN ACCESSWIRE
08:45AM  AbbVie Is Up After Another Analyst Reconsidered Its Allergan Acquisition and Upgraded the Stock Barrons.com
Sep-24-19 05:50PM  Allergan (AGN) Stock Moves -0.1%: What You Should Know Zacks
02:54PM  3 Stocks Thriving on Competitors' Failures GuruFocus.com
10:12AM  The Zacks Analyst Blog Highlights: Bristol-Myers, Lockheed, Alphabet, Allergan and Kinder Morgan Zacks
10:02AM  Fast-growing Atlanta biomedical company hires new CEO American City Business Journals
Sep-23-19 02:28PM  Top Analyst Reports for Bristol-Myers Squibb, Lockheed Martin & Alphabet Zacks
01:19PM  SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies Is Fair to Shareholders AGN, ORIT, MCRN, GHDX GlobeNewswire
01:09PM  Fast-growing Atlanta biomedical company hires new CEO American City Business Journals
03:37AM  FDA Warns About Safety of Breast Implant: 3 Stocks at Risk (Revised) Zacks
Sep-19-19 02:31PM  Ironwood Amends Linzess Agreement with AstraZeneca in China Zacks
11:15AM  11 Most Aggressively Shorted Stocks Benzinga
09:31AM  FDA Warns About Safety of Breast Implant: 3 Stocks at Risk Zacks
03:20AM  5 Undervalued Stocks to Buy InvestorPlace
Sep-18-19 12:27PM  Establishment Labs Poised to Capitalize on Allergan Breast Implant Issues GuruFocus.com
Sep-17-19 04:15PM  Announcement under the Irish Takeover Rules: Relevant Securities in Issue - September 17, 2019 PR Newswire
03:30PM  Could Algernon Pharmaceuticals Inc.'s (CNSX:AGN) Investor Composition Influence The Stock Price? Simply Wall St.
07:30AM  Allergan Announces Commencement of Mailing of Proxy Statement PR Newswire
Sep-16-19 05:50PM  Allergan (AGN) Dips More Than Broader Markets: What You Should Know Zacks
09:01AM  AbbVie Inc. -- Moody's assigns Baa2 to AbbVie's euro notes; stable outlook Moody's
Sep-13-19 11:08AM  Ardelyx Gets FDA Approval for Ibsrela As IBS-C Treatment Zacks
09:46AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others Zacks
Sep-12-19 07:25PM  Seth Klarman's Favorite Health Care Stocks GuruFocus.com
06:22PM  Consumer groups, unions urge caution on $63 billion AbbVie deal for Allergan Reuters
06:11PM  Consumer groups, unions urge caution on $63 bln AbbVie deal for Allergan Reuters
04:09PM  Humira Sales Will Crash To $3 Billion Why AbbVie Stock Got An Upgrade Investor's Business Daily
11:47AM  Buy AbbVie Stock, Because Its Deal for Allergan Just Might Work, Analyst Says Barrons.com
Sep-11-19 06:01AM  Allergan's Filings for Abicipar Pegol Accepted in U.S/Europe Zacks
Sep-10-19 05:45PM  Allergan (AGN) Outpaces Stock Market Gains: What You Should Know Zacks
04:36PM  Allergan Shareholder Meetings Scheduled for October 14, 2019 PR Newswire
Sep-09-19 11:33AM  The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers Zacks
09:19AM  U.S. judge denies bid to dismiss claim opioids are a public nuisance Reuters
07:30AM  Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration PR Newswire
Sep-06-19 03:07PM  ETFs Poised to Benefit from Gene Editing Revolution Zacks
01:29PM  UPDATE 1-Mallinckrodt to pay $24 mln in cash to settle opioid lawsuits with two Ohio counties Reuters
11:36AM  Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs Zacks
Sep-05-19 04:51PM  3 Special Situations Gurus Are Buying GuruFocus.com
10:35AM  Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease Zacks
09:31AM  Allergan (AGN) Up 1.8% Since Last Earnings Report: Can It Continue? Zacks
03:10AM  [video]Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy TheStreet.com
Sep-04-19 05:50PM  Allergan (AGN) Outpaces Stock Market Gains: What You Should Know Zacks
04:22PM  Why The Opioid Epidemic Just Got More Complicated For Generic Pharmas Investor's Business Daily
10:31AM  Ardelyx (ARDX) Gains on Tenapanor's Success in Pivotal Study Zacks
Sep-03-19 07:30AM  Allergan Receives FDA Approval of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula PR Newswire
Sep-02-19 09:41AM  Allergan Settles Ahead of Multi-District Opioid Litigation Zacks
Aug-30-19 10:03AM  Allergan Settles to Get Out Of First Big Opioid Trial Barrons.com
09:57AM  Its Not All Bad News for Generic-Drug Companies. Sales Rose in July. Barrons.com
08:00AM  Will Opioid Litigation Take its Toll on Pharma Companies? Zacks
07:09AM  Allergan settles with 2 Ohio plaintiffs in federal opioid litigation MarketWatch
07:00AM  Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation PR Newswire
05:39AM  [video]Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation TheStreet.com
Aug-28-19 04:29PM  What Purdue's Rumored Deal Means For Other Opioid-Tied Pharmas Investor's Business Daily
Aug-27-19 02:03PM  Should You Buy AbbVie for the Dividend? Motley Fool
11:01AM  J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case Zacks
Aug-23-19 10:36AM  Amgen Presents Positive Data From Rituxan Biosimilar Study Zacks
10:15AM  J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week Zacks
04:59AM  Hedge Funds Pile Into Health Care Investopedia
Aug-22-19 09:00AM  Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab) PR Newswire
Aug-21-19 04:15PM  Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms? Investor's Business Daily
01:38PM  Endo Up on Settlement of a Few Cases Related to Opioid Drugs Zacks
01:11PM  Goldman Warns Hedge Fund Outperformance Holds Crowding Risk Bloomberg
07:15AM  AbbVie Stock Slipped to a New Low, and One Exec Scooped Up Shares Barrons.com
Aug-20-19 12:20PM  Endo, Allergan could avoid trial with opioid settlements Yahoo Finance Video
11:06AM  Buy AbbVie Stock Because You Cant Ignore How Cheap It Is Barrons.com
10:15AM  Endo, Allergan could avoid trial with Ohio over opioid crisis Yahoo Finance Video
09:44AM  Here's Why Allergan is Outperforming Its Industry Of Late Zacks
06:43AM  Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit TheStreet.com
03:23AM  [video]Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report TheStreet.com
Aug-19-19 02:45PM  Obesity Epidemic Leads To A New Problem And It Could Be Worth Billions Investor's Business Daily
Aug-15-19 12:50PM  Seth Klarman's Baupost Boosts Liberty, Reduces eBay GuruFocus.com
Aug-14-19 07:59AM  Correction: Allergan sale Financial Times
12:00AM  Elliott bags Goldmans Barg Financial Times
Aug-13-19 10:59AM  Implied Volatility Surging for Allergan (AGN) Stock Options Zacks
10:48AM  Here's Why Amgen Stock is Outperforming Its Industry Of Late Zacks
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has a collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and gene therapy research collaboration with The National Institute for Bioprocessing Research and Training. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E63.17 EPS (ttm)4.00 Insider Own0.10% Shs Outstand270.25M Perf Week2.07%
Market Cap68.36B Forward P/E19.52 EPS next Y12.96 Insider Trans-24.64% Shs Float269.23M Perf Month-2.02%
Income1.10B PEG6.32 EPS next Q3.31 Inst Own88.90% Short Float1.74% Perf Quarter-0.35%
Sales17.11B P/S4.00 EPS this Y-34.50% Inst Trans0.29% Short Ratio4.74 Perf Half Y11.98%
Book/sh79.54 P/B3.18 EPS next Y10.91% ROA1.50% Target Price267.38 Perf Year6.14%
Cash/sh1.98 P/C127.77 EPS next 5Y10.00% ROE3.70% 52W Range208.62 - 264.74 Perf YTD12.26%
Dividend3.08 P/FCF84.60 EPS past 5Y-8.30% ROI3.00% 52W High-4.46% Beta1.10
Dividend %1.22% Quick Ratio0.70 Sales past 5Y14.70% Gross Margin47.40% 52W Low21.24% ATR4.46
Employees76032 Current Ratio1.10 Sales Q/Q1.70% Oper. Margin13.00% RSI (14)51.63 Volatility1.32% 1.70%
OptionableYes Debt/Eq0.94 EPS Q/Q-39.10% Profit Margin4.60% Rel Volume0.99 Prev Close252.94
ShortableYes LT Debt/Eq0.84 EarningsNov 05 BMO Payout105.30% Avg Volume988.26K Price252.94
Recom1.90 SMA200.72% SMA500.10% SMA2003.28% Volume0 Change0.00%
May-13-19Upgrade Barclays Equal Weight → Overweight $266
Dec-07-18Initiated Deutsche Bank Buy $280
Oct-16-18Initiated Barclays Equal Weight $278
Jun-21-18Upgrade JP Morgan Neutral → Overweight
Apr-10-18Upgrade Citigroup Neutral → Buy
Jan-19-18Resumed BofA/Merrill Buy $260
Jan-05-18Upgrade Citigroup Sell → Neutral
Jan-05-18Initiated KeyBanc Capital Mkts Overweight
Jan-03-18Initiated Evercore ISI Outperform
Dec-29-17Reiterated Deutsche Bank Buy $239 → $260
Nov-03-17Reiterated RBC Capital Mkts Sector Perform $210 → $230
Sep-22-17Initiated Wells Fargo Outperform $225
Jun-30-17Upgrade Raymond James Outperform → Strong Buy
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-19 04:18PM  Hedge Funds Are Buying Becton, Dickinson and Company (BDX) Insider Monkey
Oct-07-19 10:17AM  Thermo Fisher Closes API Site Buyout, Fortifies Pharma Unit Zacks
08:06AM  Is Becton Dickinson's (NYSE:BDX) Share Price Gain Of 101% Well Earned? Simply Wall St.
Oct-06-19 07:55PM  Top 5 Recession Stocks Investopedia
Oct-03-19 04:15PM  BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call PR Newswire
Sep-28-19 04:19PM  BD Announces Publication of an Independent Analysis of Drug-Coated Balloon Safety Data for Femoropopliteal Peripheral Arterial Disease PR Newswire
Sep-26-19 07:09AM  Becton Dickinson names COO Thomas Polen as CEO effective Jan. 28 MarketWatch
06:59AM  BD Announces Leadership Succession Plan PR Newswire
04:21AM  Becton Dickinson's Operating Chief Polen to Be Named CEO TheStreet.com
Sep-24-19 01:38PM  quot;Healthyquot; Dividend Aristocrats: 6 Great Health-Care Dividends Kiplinger
Sep-18-19 10:07AM  Have Insiders Been Selling Becton, Dickinson and Company (NYSE:BDX) Shares This Year? Simply Wall St.
Sep-11-19 09:10AM  Cybersecurity a Top Priority for Healthcare: 3 Stocks to Watch Zacks
Sep-10-19 12:15PM  Becton, Dickinson And Co (BDX) Chairman, CEO and President Vincent A Forlenza Sold $3 million ... GuruFocus.com
Sep-05-19 09:31AM  Why Is Becton Dickinson (BDX) Up 4.1% Since Last Earnings Report? Zacks
Sep-04-19 06:38PM  Morgan Stanley Institutional Global Franchise Fund Buys Becton, Dickinson and Co, Sells The ... GuruFocus.com
Sep-02-19 06:03AM  Dividend Investors: Don't Be Too Quick To Buy Becton, Dickinson and Company (NYSE:BDX) For Its Upcoming Dividend Simply Wall St.
Aug-31-19 09:58AM  What Kind Of Shareholder Owns Most Becton, Dickinson and Company (NYSE:BDX) Stock? Simply Wall St.
Aug-29-19 06:15PM  Becton, Dickinson And Co (BDX) EVP of Integrated Supply Chain Alexandre Conroy Sold $2. ... GuruFocus.com
04:31PM  China Ups Tariffs On Medical Devices Are These Stocks Sweating? Investor's Business Daily
Aug-27-19 09:13AM  3 Dividend Aristocrats to Buy and Hold Forever Motley Fool
Aug-23-19 02:00PM  5 Healthcare Stocks to Buy for Healthy Dividends InvestorPlace
Aug-21-19 04:30PM  BD to Present at Investor Healthcare Conferences PR Newswire
12:05PM  The Zacks Analyst Blog Highlights: Estee Lauder, Becton, Dickinson, Applied Materials, Regeneron and HollyFrontier Zacks
Aug-20-19 02:28PM  Top Analyst Reports for Estee Lauder, Becton, Dickinson & Applied Materials Zacks
Aug-16-19 09:20AM  Teledyne Technologies, Netgear, Boston Scientific, Medtronic and Becton Dickinson highlighted as Zacks Bull and Bear of the Day Zacks
Aug-15-19 10:15AM  FDA Resets PAD Guidelines: The Road Ahead for Device Makers Zacks
09:44AM  Cardiovascular Systems Set to Present LIBERTY 360 Outcome Zacks
Aug-14-19 01:18PM  A Look At The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX) Simply Wall St.
Aug-13-19 02:23PM  Becton, Dickinson Accelerates Its Growth Motley Fool
Aug-09-19 09:40AM  9 Super-Safe-Growth Stocks for Long-Lasting Dividends InvestorPlace
Aug-06-19 07:59PM  Edited Transcript of BDX earnings conference call or presentation 6-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
04:23PM  Becton Dickinson & Co. (BDX) Q3 2019 Earnings Call Transcript Motley Fool
10:28AM  China Arrests Yuan's Plunge. Will Markets Gain? Zacks
10:07AM  Stock Market News For Aug 6, 2019 Zacks
09:53AM  Index Futures Rebound as China Arrests Yuan Plunge Zacks
08:25AM  Becton, Dickinson (BDX) Beats on Q3 Earnings and Revenues Zacks
08:16AM  Becton Dickinson Reports Mixed Q3 Earnings, Reaffirms Guidance Benzinga
07:30AM  Becton Dickinson (BDX) Q3 Earnings and Revenues Top Estimates Zacks
06:00AM  BD Announces Results For 2019 Third Fiscal Quarter; Reaffirms Fiscal 2019 Guidance PR Newswire
02:03AM  Becton Dickinson Earnings Beat, Revenue Misses In Q3 Investing.com
Aug-05-19 08:37AM  Should You Buy Becton, Dickinson (BDX) Ahead of Earnings? Zacks
Aug-01-19 07:20PM  Acquisition Boosts Exact Sciences' Role in Cancer Diagnostics GuruFocus.com
Jul-31-19 09:05AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings? Zacks
05:10AM  10 Bargain Blue Chips Seen Surging As Fed Lowers Rates Investopedia
Jul-30-19 10:38AM  Becton Dickinson (BDX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-29-19 10:04AM  What's in the Cards for DaVita (DVA) This Earnings Season? Zacks
07:59AM  Should We Be Cautious About Becton, Dickinson and Company's (NYSE:BDX) ROE Of 5.1%? Simply Wall St.
Jul-27-19 12:17PM  10 Biggest Medical Device Stocks Motley Fool
Jul-23-19 06:59AM  BD releases 2018 Sustainability Report PR Newswire
Jul-22-19 05:11PM  BD Board Declares Dividends PR Newswire
Jul-18-19 09:19AM  IVD Market Sustains Momentum: 3 Stocks in Focus Zacks
06:59AM  BD Provides Update on Voluntary Recalls of Alaris Pump Module Model 8100 and Certain Alaris Pump Infusion Sets PR Newswire
Jul-09-19 10:43AM  What does Becton, Dickinson and Company's (NYSE:BDX) Balance Sheet Tell Us About Its Future? Simply Wall St.
Jul-02-19 04:15PM  BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call PR Newswire
Jun-26-19 08:00AM  A Mutual-Fund Fixer Designs His Own Fund, With Flexibility in Mind Barrons.com
Jun-24-19 04:34PM  Becton, Dickinson and Company -- Moody's announces completion of a periodic review of ratings of Becton, Dickinson and Company Moody's
Jun-20-19 05:45PM  BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices PR Newswire
03:03PM  Top Research Reports for Adobe, Charter Communications & HCA Healthcare Zacks
Jun-18-19 08:05AM  Merit Medical Acquires Brightwater Medical for $35 Million Zacks
Jun-13-19 09:33PM  Here is What Hedge Funds Think About Becton, Dickinson and Company (BDX) Insider Monkey
Jun-12-19 01:16PM  Is There Now An Opportunity In Becton, Dickinson and Company (NYSE:BDX)? Simply Wall St.
Jun-08-19 09:30AM  Why Is Becton Dickinson (BDX) Up 3.7% Since Last Earnings Report? Zacks
04:47AM  Is Budimex SA's (WSE:BDX) ROE Of 35% Impressive? Simply Wall St.
Jun-04-19 02:51PM  BD Announces Pricing and Upsizing of Tender Offers PR Newswire
06:59AM  New Report Sheds Light on Health Care's 'Hidden' Epidemic - Hospital Drug Diversion - and its Role in the Opioid Crisis PR Newswire
Jun-03-19 08:11PM  BD Announces Early Tender Results PR Newswire
May-31-19 04:05PM  BD to Present at the Goldman Sachs 40th Annual Global Healthcare Conference PR Newswire
May-22-19 08:59AM  Would Becton, Dickinson and Company (NYSE:BDX) Be Valuable To Income Investors? Simply Wall St.
May-20-19 10:26AM  Becton Dickinson Euro Finance S.a.r.l. -- Moody's assigns Ba1 rating to Becton Dickinson's proposed euro note offering Moody's
03:46AM  Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR Newswire
May-16-19 03:12PM  Becton, Dickinson Muscles Through a Tough Quarter Motley Fool
May-15-19 09:30AM  Becton, Dickinson and Company -- Moody's affirms Becton Dickinson's ratings (CFR at Ba1), outlook revised to positive Moody's
May-14-19 01:15PM  The Charts of Becton, Dickinson Need More 'Work' Before a Rally TheStreet.com
07:30AM  Jim Cramer Gives His Opinion On Becton Dickinson, Fox, Puma Biotech And More Benzinga
May-13-19 11:43AM  Barclays Upgrades Becton Dickinson, Says Market Overreacted To FDA's Drug-Coated Balloon Update Benzinga
04:17AM  Is Budimex SA's (WSE:BDX) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
May-09-19 03:52PM  Edited Transcript of BDX earnings conference call or presentation 9-May-19 12:00pm GMT Thomson Reuters StreetEvents
12:23PM  Becton Dickinson & Co. (BDX) Q2 2019 Earnings Call Transcript Motley Fool
10:02AM  Stock Market News For May 9, 2019 Zacks
09:46AM  Becton Dickinson's stock drops after profit, revenue growth outlook cut MarketWatch
08:39AM  Becton, Dickinson (BDX) Q2 Earnings Beat, Revenues Fall Y/Y Zacks
07:30AM  Becton Dickinson (BDX) Q2 Earnings Beat Estimates Zacks
06:08AM  Becton Dickinson: Fiscal 2Q Earnings Snapshot Associated Press
06:00AM  BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance PR Newswire
May-08-19 04:49PM  Becton, Dickinson Expected to Earn $2.58 a Share TheStreet.com
May-03-19 08:29AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q2 Earnings? Zacks
May-02-19 10:32AM  Analysts Estimate Becton Dickinson (BDX) to Report a Decline in Earnings: What to Look Out for Zacks
May-01-19 04:15PM  BD to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference PR Newswire
Apr-30-19 11:10AM  Does Becton, Dickinson and Company's (NYSE:BDX) CEO Pay Compare Well With Peers? Simply Wall St.
06:59AM  BD Receives FDA Approval for Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation PR Newswire
Apr-29-19 04:15PM  BD Board Declares Dividends PR Newswire
Apr-25-19 09:24AM  The Zacks Analyst Blog Highlights: Celgene, Schlumberger, Becton, Dickinson, Twitter and PPG Industries Zacks
Apr-24-19 03:36PM  Top Analyst Reports for Celgene, Schlumberger & Becton, Dickinson Zacks
Apr-22-19 02:00PM  Top Stock Reports for IBM, Honeywell & American Express Zacks
Apr-17-19 03:14PM  5 Dividend Stocks Perfect for Retirees InvestorPlace -5.90%
Apr-16-19 12:15PM  10 Dividend Growth Stocks You Cant Miss InvestorPlace
Apr-11-19 10:50AM  The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors Zacks
Apr-10-19 02:12PM  Top Stock Reports for Eli Lilly, Altria & Becton Dickinson Zacks
Apr-09-19 09:51AM  BD Introduces New Product to Reduce the Risk of Sepsis Zacks
Apr-08-19 12:22PM  Heres why Becton, Dickinson and Companys (NYSE:BDX) Returns On Capital Matters So Much Simply Wall St.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, monoclonal antibodies and kits, reagent systems, bench-side solutions, and molecular indexing and next-generation sequencing sample preparation products, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, thoracic and abdominal drainage, and surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bodner Charles RSVP Corp Fin Chief Acct OfficeSep 06Option Exercise134.733,143423,4565,180Sep 09 01:19 PM
Polen Thomas E JrExecutive Vice PresidentSep 06Option Exercise150.1213,7602,065,65130,215Sep 09 01:50 PM
Lim James CExecutive Vice PresidentSep 06Option Exercise108.8915,8481,725,68933,041Sep 09 10:55 AM
FORLENZA VINCENT AChairman, CEO and PresidentSep 06Option Exercise76.6416,3431,252,528237,431Sep 10 10:50 AM
FORLENZA VINCENT AChairman, CEO and PresidentSep 06Sale260.3811,5323,002,702221,088Sep 10 10:50 AM
Lim James CExecutive Vice PresidentSep 06Sale263.539,2992,450,56517,193Sep 09 10:55 AM
Polen Thomas E JrExecutive Vice PresidentSep 06Sale260.265,8231,515,49416,455Sep 09 01:50 PM
Bodner Charles RSVP Corp Fin Chief Acct OfficeSep 06Sale260.081,514393,7612,037Sep 09 01:19 PM
Conroy AlexandreEVP of Integrated Supply ChainAug 30Sale256.724611,80916,489Sep 03 09:47 AM
Conroy AlexandreEVP of Integrated Supply ChainAug 29Sale255.069,8292,506,98516,535Aug 29 04:39 PM
Lim James CExecutive Vice PresidentAug 09Option Exercise75.2133,9662,554,73139,902Aug 12 11:21 AM
Lim James CExecutive Vice PresidentAug 09Sale253.3123,8796,048,78917,193Aug 12 11:21 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 09Sale253.7812732,23015,930Aug 12 09:57 AM
Goette RolandEVP and President, EMEAAug 08Option Exercise75.632,463186,2778,710Aug 09 10:49 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 08Option Exercise224.942,865644,45319,072Aug 09 11:11 AM
Lim James CExecutive Vice PresidentAug 08Option Exercise76.642,773212,52319,966Aug 09 10:09 AM
Lim James CExecutive Vice PresidentAug 08Sale252.011,929486,12717,193Aug 09 10:09 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 08Sale246.5540098,62016,057Aug 09 11:11 AM
Goette RolandEVP and President, EMEAAug 08Sale249.881,717429,0446,247Aug 09 10:49 AM
Fraser ClaireDirectorAug 07Sale243.261,429347,61921,544Aug 07 02:56 PM
Campion Simon DEVP and Segment PresidentJun 12Sale236.942,903687,8379,408Jun 13 01:57 PM
Kaltenbach PatrickEVP & Pres Life SciencesJun 10Option Exercise224.942,865644,45319,072Jun 11 09:24 AM
Kaltenbach PatrickEVP & Pres Life SciencesJun 10Sale241.0319146,03716,207Jun 11 09:24 AM
Kaltenbach PatrickEVP & Pres Life SciencesJun 04Sale235.0027564,62516,207Jun 05 01:25 PM
Khichi Samrat S.EVP and General CounselMay 21Sale234.6816,0853,774,82812,608May 23 12:30 PM
Larson Betty DEVP HR & CHROMay 13Option Exercise97.142,200213,70811,493May 14 02:02 PM
Larson Betty DEVP HR & CHROMay 13Sale224.971,700382,4478,843May 14 02:02 PM
BURZIK CATHERINE MDirectorApr 17Sale223.044510,03710,007May 30 01:12 PM
BURZIK CATHERINE MDirectorApr 16Buy247.96307,43910,052May 30 01:12 PM
Mas Ribo AlbertoEVP and Pres, Life SciencesMar 15Option Exercise108.893,483379,26419,074Mar 18 10:13 AM
FORLENZA VINCENT AChairman, CEO and PresidentMar 15Option Exercise76.6411,878910,330222,785Mar 18 10:27 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesMar 15Sale255.002,104536,52015,482Mar 18 10:13 AM
FORLENZA VINCENT AChairman, CEO and PresidentMar 15Sale255.138,3092,119,875210,907Mar 18 10:27 AM
FORLENZA VINCENT AChairman, CEO and PresidentMar 04Option Exercise76.644,465342,198215,372Mar 06 03:05 PM
Mas Ribo AlbertoEVP and Pres, Life SciencesMar 04Option Exercise108.894,864529,64122,476Mar 06 03:05 PM
Mas Ribo AlbertoEVP and Pres, Life SciencesMar 04Sale255.034,8081,226,18415,591Mar 06 03:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentMar 04Sale255.033,123796,459210,907Mar 06 03:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentFeb 25Option Exercise76.6416,3431,252,528227,250Feb 25 02:58 PM
FORLENZA VINCENT AChairman, CEO and PresidentFeb 25Sale250.4011,3402,839,536210,907Feb 25 02:58 PM
Borzi James WEVP & Chief Supply Chain OffcrNov 30Option Exercise153.8410,4051,600,68710,654Dec 03 09:43 AM
Borzi James WEVP & Chief Supply Chain OffcrNov 30Sale252.375,8871,485,6922,775Dec 03 09:43 AM
Polen Thomas E JrExecutive Vice PresidentNov 19Option Exercise134.7311,7181,578,76623,896Nov 19 05:26 PM
Polen Thomas E JrExecutive Vice PresidentNov 19Sale243.865,2431,278,55812,178Nov 19 05:26 PM
Bodner Charles RSVP Corp Fin Chief Acct OfficeNov 16Option Exercise134.732,500336,8254,497Nov 16 04:41 PM
Bodner Charles RSVP Corp Fin Chief Acct OfficeNov 16Sale245.832,080511,3281,047Nov 16 04:41 PM
FORLENZA VINCENT AChairman, CEO and PresidentNov 14Option Exercise76.6420,0001,532,800228,883Nov 16 01:35 PM
Mas Ribo AlbertoEVP and Pres, Life SciencesNov 14Sale237.014,5301,073,65514,596Nov 16 09:18 AM
FORLENZA VINCENT AChairman, CEO and PresidentNov 14Sale235.7813,4983,182,558194,310Nov 16 01:35 PM
Lim James CExecutive Vice PresidentNov 08Sale242.365,1891,257,60613,318Nov 08 02:08 PM
RING TIMOTHY MDirectorNov 07Sale237.0742,0009,956,94093,688Nov 08 09:32 AM
CF CF Industries Holdings, Inc. daily Stock Chart
CF [NYSE]
CF Industries Holdings, Inc.
IndexS&P 500 P/E23.48 EPS (ttm)2.08 Insider Own0.30% Shs Outstand221.10M Perf Week0.14%
Market Cap10.81B Forward P/E16.46 EPS next Y2.97 Insider Trans-27.85% Shs Float217.42M Perf Month-3.30%
Income468.00M PEG- EPS next Q0.36 Inst Own98.30% Short Float1.55% Perf Quarter4.11%
Sales4.68B P/S2.31 EPS this Y330.20% Inst Trans0.68% Short Ratio1.57 Perf Half Y9.61%
Book/sh13.87 P/B3.53 EPS next Y24.67% ROA3.50% Target Price54.55 Perf Year-3.70%
Cash/sh3.88 P/C12.60 EPS next 5Y- ROE14.60% 52W Range38.90 - 55.15 Perf YTD12.41%
Dividend1.20 P/FCF12.18 EPS past 5Y-23.40% ROI8.70% 52W High-11.31% Beta0.96
Dividend %2.45% Quick Ratio1.10 Sales past 5Y-4.20% Gross Margin24.30% 52W Low25.73% ATR1.32
Employees2900 Current Ratio1.40 Sales Q/Q15.50% Oper. Margin20.80% RSI (14)48.51 Volatility2.42% 2.46%
OptionableYes Debt/Eq1.53 EPS Q/Q102.10% Profit Margin9.70% Rel Volume0.87 Prev Close48.91
ShortableYes LT Debt/Eq1.37 EarningsOct 30 AMC Payout59.30% Avg Volume2.14M Price48.91
Recom2.50 SMA20-0.35% SMA50-0.09% SMA2008.56% Volume0 Change0.00%
Sep-26-19Reiterated Cowen Outperform $59 → $62
Sep-23-19Initiated Consumer Edge Research Overweight
Aug-05-19Upgrade BofA/Merrill Underperform → Neutral
May-15-19Reiterated Cowen Outperform $56 → $54
Apr-23-19Reiterated Cowen Outperform $62 → $56
Apr-18-19Downgrade BofA/Merrill Buy → Underperform $50 → $38
Mar-06-19Reiterated Cowen Outperform $68 → $62
Jan-14-19Downgrade Bernstein Outperform → Mkt Perform
Dec-19-18Upgrade Stephens Equal-Weight → Overweight
Nov-02-18Upgrade Citigroup Neutral → Buy
Oct-31-18Upgrade BofA/Merrill Underperform → Buy
Oct-04-18Reiterated Cowen Outperform $60 → $68
Sep-04-18Initiated Barclays Equal Weight $55
Aug-08-18Upgrade HSBC Securities Hold → Buy
Jul-18-18Upgrade RBC Capital Mkts Underperform → Sector Perform
May-15-18Reiterated Stifel Hold $37 → $43
Mar-29-18Initiated Berenberg Hold $38
Mar-13-18Downgrade Citigroup Buy → Neutral
Mar-08-18Downgrade BofA/Merrill Buy → Underperform
Feb-21-18Initiated Bernstein Outperform $60
Oct-17-19 07:15AM  Have Insiders Been Selling CF Industries Holdings, Inc. (NYSE:CF) Shares This Year? Simply Wall St.
06:12AM  Bear of the Day: Mosaic (MOS) Zacks
Oct-16-19 11:59AM  FMC and Corteva Are 2 Stocks to Help Counter Agricultures Lost Year Barrons.com
Oct-15-19 01:43PM  Buy Deere Stock After the Corn Bombshell Was a Dud, Analysts Say Barrons.com
Oct-09-19 04:35PM  CF Industries Holdings, Inc. Declares Quarterly Dividend Business Wire
04:30PM  CF Industries Holdings, Inc. To Redeem Senior Notes Due May 2020 Business Wire
Sep-29-19 09:52AM  Is There An Opportunity With CF Industries Holdings, Inc.'s (NYSE:CF) 24% Undervaluation? Simply Wall St.
Sep-19-19 09:01AM  CF Industries (CF) Shares Rise 22% in 6 Months: Here's Why Zacks
Sep-11-19 11:58AM  CF Industries Holdings (NYSE:CF) Seems To Use Debt Quite Sensibly Simply Wall St.
Sep-03-19 07:15PM  Cf Industries Holdings Inc (CF) Sr VP and CFO Dennis P. Kelleher Sold $4.6 million of Shares GuruFocus.com
05:19PM  CF Industries Holdings, Inc. to Participate in Upcoming Investor Conferences Business Wire
Aug-29-19 09:15AM  Dow Jumps 1% Despite Yield Curve Worries Zacks
Aug-26-19 06:42AM  What Did CF Industries Holdings, Inc.'s (NYSE:CF) CEO Take Home Last Year? Simply Wall St.
Aug-22-19 08:20AM  CF Industries (CF) Up 21% in 3 Months: What's Driving It? Zacks
Aug-12-19 08:12AM  Zacks.com featured highlights include: CF Industries, PaySign and Hertz Global Zacks
Aug-09-19 07:45AM  Upgraded Broker Ratings Make These 3 Stocks Worth Buying Now Zacks
07:07AM  CF Industries Holdings, Inc. (NYSE:CF) Goes Ex-Dividend In 4 Days Simply Wall St.
Aug-07-19 03:34AM  Edited Transcript of CF earnings conference call or presentation 1-Aug-19 3:00pm GMT Thomson Reuters StreetEvents
Aug-05-19 11:00AM  Bank Of America Upgrades CF Industries On Strong Q2, Improving 2020 Outlook Benzinga
Aug-04-19 09:14AM  Is CF Industries Holdings, Inc. (NYSE:CF) A Smart Choice For Dividend Investors? Simply Wall St.
Aug-02-19 11:04AM  CF Industries (CF) Looks Good: Stock Adds 5.6% in Session Zacks
07:59AM  Will CF Industries Continue to Surge Higher? Zacks
Aug-01-19 08:24PM  CF Industries Holdings Inc (CF) Q2 2019 Earnings Call Transcript Motley Fool +5.63%
04:35PM  US Stocks Deep in the Red on Thursday GuruFocus.com
01:17PM  Why Shares of CF Industries Are Climbing Today Motley Fool
08:54AM  CF Industries' (CF) Earnings & Sales Beat Estimates in Q2 Zacks
Jul-31-19 06:05PM  CF Industries (CF) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:45PM  CF Industries Holdings, Inc. Reports First Half 2019 Net Earnings of $373 Million, EBITDA of $973 Million Business Wire
07:24AM  3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco InvestorPlace
Jul-30-19 01:30PM  Wall Street Down Tuesday GuruFocus.com
Jul-29-19 08:44AM  What's in the Cards for CF Industries' (CF) Q2 Earnings? Zacks
Jul-24-19 10:32AM  CF Industries (CF) Earnings Expected to Grow: Should You Buy? Zacks
07:58AM  3 Big Stock Charts for Wednesday: KeyCorp, CF Industries and General Electric InvestorPlace
Jul-18-19 05:30PM  CF Industries Holdings, Inc. Declares Quarterly Dividend Business Wire
05:30PM  CF Industries Holdings, Inc. Announces Dates for Second Quarter 2019 Results and Conference Call Business Wire
03:37PM  Bet on Mispriced Stocks with These ETFs Zacks
11:36AM  Is CF Industries Holdings, Inc.'s (NYSE:CF) ROE Of 8.1% Concerning? Simply Wall St.
Jul-15-19 05:34PM  Wall Street Mixed on Monday GuruFocus.com
Jul-08-19 11:55AM  CF Industries Stock Is Poised to Change Direction TheStreet.com
06:32AM  Bear of the Day: Mosaic (MOS) Zacks
Jul-05-19 04:54PM  Extreme weather takes economic toll on Midwest, damages total $12.5 billion Yahoo Finance
Jul-03-19 09:15AM  S&P Makes It Two Record Closes in a Row Zacks
Jul-02-19 06:51AM  Here's What CF Industries Holdings, Inc.'s (NYSE:CF) P/E Is Telling Us Simply Wall St.
Jun-20-19 08:11AM  3 Big Stock Charts for Thursday: CF Industries, Nordstrom and WellCare Health Plans InvestorPlace
Jun-19-19 09:15AM  They Meet, We Rally Zacks
Jun-17-19 06:35AM  Adnoc, OCI Merge Mideast Assets With $1.7 Billion Sales Bloomberg
Jun-14-19 10:16AM  How Financially Strong Is CF Industries Holdings, Inc. (NYSE:CF)? Simply Wall St.
Jun-10-19 08:43AM  Is CF Industries Holdings, Inc. (CF) A Good Stock To Buy? Insider Monkey
Jun-04-19 12:00AM  Jean-Charles Naouri puts the computer in his brain to the test Financial Times +5.07%
May-31-19 09:31AM  CF (CF) Down 6.6% Since Last Earnings Report: Can It Rebound? Zacks
08:30AM  CF Industries Dennis P. Kelleher to Retire as Chief Financial Officer September 1, 2019; Christopher D. Bohn Named Successor; Ashraf Malik Named New SVP, Manufacturing & Distribution Business Wire
May-30-19 03:00PM  Is CF Industries Holdings, Inc.'s (NYSE:CF) Balance Sheet A Threat To Its Future? Simply Wall St.
May-21-19 01:49PM  The Top 5 Buys of T Boone Pickens' BP Capital GuruFocus.com
May-11-19 09:11AM  Does CF Industries Holdings's (NYSE:CF) Share Price Gain of 51% Match Its Business Performance? Simply Wall St.
May-10-19 11:39PM  Edited Transcript of CF earnings conference call or presentation 2-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-06-19 04:25PM  CF Industries Holdings, Inc. to Participate in Upcoming Investor Conferences Business Wire
May-02-19 04:09PM  CF Industries Holdings Inc (CF) Q1 2019 Earnings Call Transcript Motley Fool
09:28AM  CF Industries' (CF) Earnings & Sales Miss Estimates in Q1 Zacks
07:00AM  CF Industries Holdings, Inc. to Host Earnings Call ACCESSWIRE
May-01-19 06:25PM  CF Industries (CF) Lags Q1 Earnings and Revenue Estimates Zacks
05:17PM  CF: 1Q Earnings Snapshot Associated Press
04:30PM  CF Industries Holdings, Inc. Reports First Quarter 2019 Net Earnings of $90 Million, EBITDA of $301 Million Business Wire
Apr-29-19 09:56AM  CF Industries (CF) to Post Q1 Earnings: What's in the Cards? Zacks
Apr-26-19 05:17PM  CF Industries Holdings, Inc. Declares Quarterly Dividend Business Wire
Apr-24-19 10:33AM  CF Industries (CF) Earnings Expected to Grow: Should You Buy? Zacks
Apr-23-19 07:20AM  Have Insiders Been Selling CF Industries Holdings, Inc. (NYSE:CF) Shares This Year? Simply Wall St.
Apr-22-19 03:30PM  CF Industries Holdings, Inc. Announces Dates for First Quarter 2019 Results and Conference Call Business Wire
08:24AM  3 Big Stock Charts for Monday: Caterpillar, Lamb Weston and CF Industries InvestorPlace
Apr-09-19 01:51PM  Heres What Hedge Funds Think About CF Industries Holdings, Inc. (CF) Insider Monkey
Apr-03-19 11:29AM  Why You Should Care About CF Industries Holdings, Inc.s (NYSE:CF) Cash Levels Simply Wall St.
Mar-28-19 07:50AM  Research Report Identifies LGI Homes, Under Armour, Frontline, Alliance Resource Partners, CF Industries, and Integra LifeSciences with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-15-19 09:30AM  Why Is CF (CF) Up 0.4% Since Last Earnings Report? Zacks
Mar-14-19 05:01AM  8 Fast-Growth Stocks That Can Lead as Bull Market Slows Investopedia
Mar-11-19 08:11AM  Why You Should Care About CF Industries Holdings, Inc.s (NYSE:CF) Low Return On Capital Simply Wall St.
Mar-07-19 02:35AM  Edited Transcript of CF earnings conference call or presentation 14-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Mar-05-19 07:40AM  3 Big Stock Charts for Tuesday: D. R. Horton, PPL and CF Industries InvestorPlace
Feb-26-19 01:01PM  25 Stocks That Could Struggle Next Month Schaeffer's Investment Research
Feb-22-19 03:48PM  CF Industries Holdings Inc (CF) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-20-19 11:26AM  Stocks - Dow Ends Higher as Materials Rally; Fed Set to Continue Pause Investing.com +6.12%
Feb-19-19 04:30PM  CF Industries Holdings, Inc. to Participate in Upcoming Investor Conference Business Wire
Feb-18-19 07:33AM  CF Industries Holdings, Inc. (NYSE:CF): Whats The Analyst Consensus Outlook? Simply Wall St.
Feb-14-19 04:06PM  Wall Street Declines on Weak Economic Data GuruFocus.com
03:30PM  CF Industries Holdings Inc (CF) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:55AM  CF Industries' (CF) Earnings & Sales Trail Estimates in Q4 Zacks
Feb-13-19 06:20PM  CF Industries (CF) Lags Q4 Earnings and Revenue Estimates Zacks
05:24PM  CF: 4Q Earnings Snapshot Associated Press
04:30PM  CF Industries Holdings, Inc. Reports Full Year 2018 Net Earnings of $290 Million, EBITDA of $1.4 Billion Business Wire
Feb-12-19 04:53PM  CF Industries Holdings, Inc. to Participate in Upcoming Investor Conference Business Wire
Feb-11-19 08:03AM  CF Industries (CF) to Post Q4 Earnings: What's in the Offing? Zacks
Feb-07-19 04:58PM  CF Industries Holdings, Inc. Announces Dates for Fourth Quarter 2018 Results and Conference Call Business Wire
Feb-06-19 10:30AM  CF Industries (CF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Feb-05-19 04:20PM  CF Industries Holdings, Inc. Declares Quarterly Dividend Business Wire
Jan-28-19 10:37AM  Does CF Industries Holdings, Inc.s (NYSE:CF) CEO Pay Reflect Performance? Simply Wall St.
Jan-18-19 05:50PM  CF Industries (CF) Gains But Lags Market: What You Should Know Zacks
Jan-16-19 03:46PM  Fertilizers Industry Outlook: Near-Term Prospects Look Bright Zacks
Jan-10-19 05:53PM  Royal Gold (RGLD) Provides Updates on Operations for Q2 Zacks
10:59AM  U.S. Silica (SLCA) Buys Millen Facility, Expands Capacity Zacks
09:34AM  The Zacks Analyst Blog Highlights: CF Industries, Nutrien and Mosaic Zacks
09:06AM  Here's Why You Should Hold LyondellBasell (LYB) Stock Now Zacks
08:13AM  VALE to Benefit From Increasing Demand Amid Cost Concerns Zacks
CF Industries Holdings, Inc. manufactures and distributes nitrogen fertilizers and other nitrogen products worldwide. Its principal nitrogen fertilizer products include ammonia, granular urea, urea ammonium nitrate solution, and ammonium nitrate. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products, as well as compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, farmers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kelleher Dennis P.Sr VP and CFOAug 30Sale48.1934,3431,654,96940,874Sep 03 05:57 PM
Kelleher Dennis P.Sr VP and CFOAug 29Option Exercise34.1153,5501,826,805136,117Sep 03 05:57 PM
Frost Bert ASr.VP,Sales,Mkt Dev & Sup ChnAug 29Option Exercise16.2621,000341,460103,072Aug 30 05:03 PM
Frost Bert ASr.VP,Sales,Mkt Dev & Sup ChnAug 29Sale48.2121,0001,012,47982,072Aug 30 05:03 PM
Kelleher Dennis P.Sr VP and CFOAug 29Sale48.2260,9002,936,58975,217Sep 03 05:57 PM
Frost Bert ASr.VP,Sales,Mkt Dev & Sup ChnAug 07Option Exercise16.4121,600354,370103,672Aug 08 04:39 PM
Frost Bert ASr.VP,Sales,Mkt Dev & Sup ChnAug 07Sale50.1621,6001,083,45682,072Aug 08 04:39 PM
Barnard Douglas CSr. VP, Gen. Coun. & SecretaryAug 05Option Exercise15.34100,5001,542,053194,998Aug 06 05:01 PM
O'Brien Rosemary LVP, Public AffairsAug 05Option Exercise16.415,00082,03037,936Aug 06 05:01 PM
O'Brien Rosemary LVP, Public AffairsAug 05Sale50.475,000252,35032,936Aug 06 05:01 PM
Barnard Douglas CSr. VP, Gen. Coun. & SecretaryAug 05Sale50.74100,5005,099,64694,498Aug 06 05:01 PM
Frost Bert ASr.VP,SalesMktDev,Supply ChainJun 03Option Exercise16.416,00098,43688,072Jun 04 04:16 PM
Hoker Richard AVP and Corporate ControllerJun 03Option Exercise16.413,66560,12867,048Jun 04 04:19 PM
Hoker Richard AVP and Corporate ControllerJun 03Sale41.153,665150,79663,383Jun 04 04:19 PM
Frost Bert ASr.VP,SalesMktDev,Supply ChainJun 03Sale41.176,000247,02482,072Jun 04 04:16 PM
FURBACHER STEPHEN ADirectorMay 07Sale42.013,000126,03047,190May 09 07:25 PM
Will W AnthonyPresident & CEONov 09Option Exercise15.38104,5001,607,093430,372Nov 13 04:09 PM
FURBACHER STEPHEN ADirectorNov 09Sale52.453,500183,56150,190Nov 13 04:10 PM
Frost Bert ASr.VP, Sales,Mkt Dev Supp ChnNov 08Option Exercise16.411,90031,17173,390Nov 13 04:12 PM
Frost Bert ASr.VP, Sales,Mkt Dev Supp ChnNov 08Sale54.001,900102,60071,490Nov 13 04:12 PM
NI NiSource Inc. daily Stock Chart
NI [NYSE]
NiSource Inc.
IndexS&P 500 P/E93.23 EPS (ttm)0.30 Insider Own0.30% Shs Outstand373.90M Perf Week-3.68%
Market Cap10.46B Forward P/E20.22 EPS next Y1.38 Insider Trans-11.62% Shs Float372.05M Perf Month-4.96%
Income123.30M PEG19.99 EPS next Q0.08 Inst Own95.00% Short Float4.22% Perf Quarter-5.47%
Sales5.24B P/S2.00 EPS this Y-121.00% Inst Trans0.35% Short Ratio5.03 Perf Half Y1.38%
Book/sh13.63 P/B2.05 EPS next Y5.90% ROA0.60% Target Price30.05 Perf Year13.01%
Cash/sh0.06 P/C441.27 EPS next 5Y4.66% ROE2.50% 52W Range24.36 - 30.67 Perf YTD10.34%
Dividend0.80 P/FCF41.47 EPS past 5Y-16.20% ROI1.90% 52W High-8.80% Beta0.23
Dividend %2.86% Quick Ratio0.30 Sales past 5Y-2.00% Gross Margin68.40% 52W Low14.80% ATR0.46
Employees8087 Current Ratio0.40 Sales Q/Q0.30% Oper. Margin7.80% RSI (14)31.57 Volatility1.97% 1.49%
OptionableYes Debt/Eq1.81 EPS Q/Q1111.80% Profit Margin2.40% Rel Volume3.14 Prev Close27.97
ShortableYes LT Debt/Eq1.40 EarningsOct 30 BMO Payout259.40% Avg Volume3.12M Price27.97
Recom2.40 SMA20-4.74% SMA50-4.42% SMA200-0.89% Volume0 Change0.00%
Aug-07-19Downgrade Credit Suisse Outperform → Neutral
Aug-05-19Downgrade Wolfe Research Outperform → Peer Perform
Jul-24-19Upgrade Argus Hold → Buy $32
Apr-22-19Downgrade BofA/Merrill Buy → Neutral
Apr-08-19Upgrade Goldman Neutral → Buy $26 → $29
Jan-07-19Upgrade Guggenheim Neutral → Buy
Oct-19-18Downgrade Mizuho Buy → Neutral
Sep-14-18Downgrade Evercore ISI In-line → Underperform
Sep-10-18Downgrade Guggenheim Buy → Neutral
May-17-18Upgrade JP Morgan Neutral → Overweight
Mar-27-18Downgrade Citigroup Buy → Neutral
Mar-23-18Upgrade BofA/Merrill Neutral → Buy
Jan-11-18Upgrade Goldman Neutral → Buy
Aug-14-17Upgrade Credit Suisse Underperform → Outperform
Aug-09-17Initiated Wells Fargo Outperform $30
May-19-17Initiated Ladenburg Thalmann Buy $27
Jan-09-17Upgrade Guggenheim Neutral → Buy
Dec-15-16Initiated Goldman Neutral
Dec-14-16Upgrade Citigroup Neutral → Buy
Oct-13-16Upgrade Jefferies Underperform → Hold
Oct-16-19 07:00AM  NiSource Appoints Nick Stavropoulos, Veteran Gas Industry Executive, to Lead Safety Efforts for Columbia Gas of Massachusetts PR Newswire
Oct-14-19 01:09PM  Is NiSource Inc. (NYSE:NI) A Risky Dividend Stock? Simply Wall St.
08:50AM  Ameren (AEE) Announces Quarterly Dividend Increase of 4.2% Zacks
Oct-12-19 03:32PM  Hedge Funds Are Snapping Up NiSource Inc. (NI) Insider Monkey
Oct-11-19 09:15AM  NiSource Named to 2019 Dow Jones Sustainability Index PR Newswire
Oct-10-19 10:30AM  NiSource Schedules Earnings Release and Conference Call for Oct. 30 PR Newswire
Sep-30-19 08:59AM  Here's Why You Should Invest in AES Corp (AES) Stock Now Zacks
Sep-26-19 01:57PM  Lawyers ask for $24M in fees for Columbia Gas settlement American City Business Journals
Sep-24-19 01:34PM  NiSource Statement on NTSB Investigation PR Newswire
Sep-17-19 03:19PM  TransAlta (TAC) Announces New Clean Energy Investment Plan Zacks
Sep-12-19 11:07AM  If You Had Bought NiSource (NYSE:NI) Shares Five Years Ago You'd Have A Total Return Of 118% Simply Wall St.
Sep-06-19 09:04AM  Is Victory Nickel (CNSX:NI) Weighed On By Its Debt Load? Simply Wall St.
Sep-05-19 08:04AM  Duke Energy Arm Seeks for Rate Hike to Recover Investments Zacks
Aug-30-19 07:53AM  NiSource's (NI) Systematic Long-Term Investments Bode Well Zacks
Aug-29-19 02:30PM  10 Stocks to Buy for September InvestorPlace
09:00AM  NiSource Releases 2018 Climate Report PR Newswire
Aug-28-19 02:14PM  Hawaiian Electric Initiates Largest Clean Energy Procurement Zacks
10:59AM  Edited Transcript of NI earnings conference call or presentation 31-Jul-19 1:00pm GMT Thomson Reuters StreetEvents
Aug-16-19 09:18AM  The Zacks Analyst Blog Highlights: Deere, Baxter, EPAM Systems, NiSource and Universal Display Zacks
Aug-15-19 02:16PM  Top Analyst Reports: Deere, Baxter & More Zacks
Aug-13-19 02:27PM  Read This Before Judging NiSource Inc.'s (NYSE:NI) ROE Simply Wall St.
Aug-06-19 04:15PM  Nisource Inc (NI) EVP and President, NIPSCO Violet Sistovaris Sold $1.2 million of Shares GuruFocus.com
04:10PM  NiSource Declares Common and Preferred Stock Dividends PR Newswire
Aug-02-19 06:00AM  Two Picks for Utility Investors- Ameren and NiSource MoneyShow
Jul-31-19 10:24PM  NiSource (NI) Q2 2019 Earnings Call Transcript Motley Fool
02:25PM  NiSource (NI) Meets Q2 Earnings Estimates, Revenues Up Y/Y Zacks
09:43AM  NiSource (NI) Q2 Earnings Meet Estimates, Revenues Miss Zacks
09:35AM  NiSource (NI) Matches Q2 Earnings Estimates Zacks
06:30AM  NiSource Reports Second Quarter 2019 Results PR Newswire
Jul-30-19 02:50PM  NiSource's Q2 Earnings Preview Benzinga
07:57AM  Utility Stock Q2 Earnings Due on Jul 31: ETR, SO & More Zacks
Jul-29-19 10:50AM  Series of gas explosion lawsuits settled for $143 million MarketWatch
10:23AM  UPDATE 1-NiSource settles Massachusetts gas explosion lawsuits for $143 million Reuters
09:59AM  NiSource To Pay $143M Settlement For Merrimack Valley Incident Benzinga
09:36AM  Columbia Gas settles Massachusetts blast lawsuits for $143 mln Reuters
08:00AM  Columbia Gas Settles All Class Action Lawsuits for Merrimack Valley Incident PR Newswire
Jul-25-19 09:33AM  NiSource (NI) to Post Q2 Earnings: What's in the Cards? Zacks
Jul-24-19 10:59AM  DTE Energy (DTE) Misses on Q2 Earnings, Hikes '19 EPS View Zacks
10:32AM  Earnings Preview: NiSource (NI) Q2 Earnings Expected to Decline Zacks
08:07AM  FirstEnergy (FE) Beats Q2 Earnings, Lags Revenue Estimates Zacks
Jul-16-19 09:25AM  National Grid (NGG) Buys Geronimo Energy for $100M, Signs JV Zacks
Jul-15-19 11:00AM  NiSource Schedules Earnings Release and Conference Call for July 31 PR Newswire
Jul-12-19 11:46AM  Is NiSource Inc.'s (NYSE:NI) CEO Pay Fair? Simply Wall St.
Jul-11-19 07:39AM  Here's Why You Should Add DTE Energy (DTE) to Your Portfolio Zacks
Jul-09-19 02:46PM  Family of Massachusetts youth killed in blast settles suit against company Reuters
Jul-08-19 08:32AM  Here's Why You Should Add Xcel Energy (XEL) to Your Portfolio Zacks
Jul-03-19 08:17AM  UGI Corp to Acquire Columbia Midstream Assets From TC Energy Zacks
Jun-27-19 01:00PM  Columbia Gas customers to see refunds in July or August bills PR Newswire
Jun-18-19 10:47AM  Heres What Hedge Funds Think About NiSource Inc. (NI) Insider Monkey
Jun-17-19 04:51PM  NiSource Plans Sale of Unit Tied to Gas Explosions Bloomberg
Jun-06-19 10:00AM  Deborah Hersman, Safety Expert and Former NTSB Chair, Joins NiSource Board of Directors PR Newswire
09:02AM  Black Hills (BKH) Unit Files Rate Review Request With WPSC Zacks
May-31-19 09:31AM  Why Is NiSource (NI) Down 0.1% Since Last Earnings Report? Zacks
May-27-19 07:19AM  How Victory Nickel Inc. (CNSX:NI) Can Impact Your Portfolio Volatility Simply Wall St.
May-24-19 08:33AM  Consolidated Edison (ED) Invests $1.5B, Lowers Customer Bills Zacks
May-21-19 08:13AM  Xcel Energy (XEL) to Replace Coal Plants With Renewables Zacks
May-17-19 03:10PM  Have Insiders Been Selling NiSource Inc. (NYSE:NI) Shares This Year? Simply Wall St.
May-15-19 06:35PM  Ameren (AEE) to Add 300 MW Third Wind Facility in Missouri Zacks
May-14-19 08:05AM  3 Big Stock Charts for Tuesday: Coty, International Paper and NiSource InvestorPlace
May-07-19 01:06PM  Columbia Gas announces $80M settlement with Merrimack Valley communities American City Business Journals
May-06-19 05:45PM  NiSource Declares Common and Preferred Stock Dividends PR Newswire
May-03-19 07:16PM  Edited Transcript of NI earnings conference call or presentation 1-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-02-19 12:23AM  NiSource (NI) Q1 2019 Earnings Call Transcript Motley Fool
May-01-19 01:16PM  NiSource (NI) Q1 Earnings and Revenues Top Estimates Zacks
11:52AM  NiSource (NI) Q1 Earnings and Revenues Surpass Estimates Zacks
06:48AM  NiSource: 1Q Earnings Snapshot Associated Press
06:30AM  NiSource Reports First Quarter 2019 Results PR Newswire
Apr-30-19 10:53AM  Columbia Gas settles with Lawrence family injured in explosions American City Business Journals
10:10AM  Why NiSource (NI) is Poised to Beat Earnings Estimates Again Zacks
08:10AM  PPL Corp (PPL) to Post Q1 Earnings: Is a Beat in Store? Zacks
Apr-26-19 10:44AM  NiSource (NI) to Post Q1 Earnings: What's in the Cards? Zacks
Apr-24-19 10:33AM  NiSource (NI) Reports Next Week: What You Should Expect Zacks
Apr-18-19 09:58AM  Xcel Energy to Take Over Wind Project Construction in Colorado Zacks
Apr-12-19 04:10PM  Kevin T. Kabat Elected NiSource Chairman PR Newswire
Apr-10-19 09:00AM  NiSource Schedules Earnings Release and Conference Call for May 1 PR Newswire
Apr-05-19 04:28PM  Heres What Hedge Funds Think About NiSource Inc. (NI) Insider Monkey
Apr-02-19 08:30AM  NiSource Highlights New Emissions Reduction Targets in 2018 Integrated Annual Report PR Newswire
Mar-22-19 10:50PM  NISOURCE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NiSource Inc. - NI Business Wire
Mar-21-19 09:35AM  Avista (AVA) Brings Additional Wind Power in Washington Zacks
06:25AM  Exclusive: Columbia Gas boss talks safety, trust and being a fix-it guy American City Business Journals
Mar-19-19 04:10PM  NiSource Declares Common and Preferred Stock Dividends PR Newswire
Mar-18-19 04:20PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NiSource Inc. (NI) ACCESSWIRE
03:52PM  Bragar Eagel & Squire, P.C. is Investigating NiSource Inc. (NI) on Behalf of Stockholders and Encourages NI Investors to Contact the Firm GlobeNewswire
Mar-16-19 02:33PM  EQUITY ALERT: Rosen Law Firm Continues Investigating NiSource Inc. for Violations of the Federal Securities Laws NI Business Wire
Mar-15-19 10:50PM  NISOURCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NiSource Inc. - NI PR Newswire
Mar-14-19 09:00AM  Secretary Ray LaHood Named Chair of NiSource's Quality Review Board, Providing External Governance for Safety Management System (SMS) Implementation PR Newswire
Mar-12-19 03:27PM  Can You Imagine How NiSources (NYSE:NI) Shareholders Feel About The 22% Share Price Increase? Simply Wall St.
07:40AM  3 Big Stock Charts for Tuesday: NiSource, PulteGroup and Nielsen Holdings InvestorPlace
Feb-27-19 10:02AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of NiSource Inc. GlobeNewswire
Feb-26-19 07:40AM  Analysis: Positioning to Benefit within Weatherford International, NiSource, Palatin Technologies, Astronics, MaxLinear, and FutureFuel Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-22-19 10:50PM  NISOURCE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NiSource Inc. - NI Business Wire
10:00AM  NiSource Provides Update on Implementation of Safety Steps Across Its Low-Pressure Systems PR Newswire
Feb-21-19 01:29PM  Edited Transcript of NI earnings conference call or presentation 20-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Feb-20-19 01:37PM  Nisource Inc (NI) Q4 2018 Earnings Conference Call Transcript Motley Fool
12:22PM  NiSource (NI) Earnings and Revenues Beat Estimates in Q4 Zacks
08:45AM  NiSource (NI) Tops Q4 Earnings and Revenue Estimates Zacks
07:09AM  NiSource: 4Q Earnings Snapshot Associated Press
06:30AM  NiSource Reports 2018 Results PR Newswire
Feb-19-19 08:11AM  Pinnacle West (PNW) to Post Q4 Earnings: Is a Beat in Store? Zacks
Feb-18-19 08:29AM  Is a Beat in Store for NiSource (NI) This Earnings Season? Zacks
NiSource Inc., an energy holding company, operates as a regulated natural gas and electric utility company in the United States. The company operates in two segments, Gas Distribution Operations and Electric Operations. It provides natural gas service and transportation for residential, commercial, and industrial customers; generates, transmits, and distributes electricity; and wholesale and transmission transaction services. The company owns and operates 2 coal-fired electric generating stations with a capacity of 2,080 megawatts (MW); combined cycle gas turbine with a capacity of 571 MW; 3 gas-fired generating units with a capacity of 186 MW; and 2 hydroelectric generating plants with a capacity of 16 MW. It serves approximately 3.5 million natural gas customers in Ohio, Pennsylvania, Virginia, Kentucky, Maryland, Indiana, and Massachusetts; and 472,000 electricity customers in the northern part of Indiana. The company was formerly known as NIPSCO Industries, Inc. and changed its name to NiSource Inc. in April 1999. NiSource Inc. was founded in 1912 and is headquartered in Merrillville, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jesanis Michael EDirectorAug 14Sale29.016,000174,08432,997Aug 15 10:57 AM
Brown Donald EugeneEVP & Chief Financial OfficerAug 06Sale28.0410,000280,40776,903Aug 07 11:18 AM
Sistovaris VioletEVP and President, NIPSCOAug 05Sale29.1640,4051,178,210105,927Aug 06 01:20 PM
Vegas PabloEVP & President, Gas UtilitiesAug 02Sale29.9439,6181,186,16335,962Aug 06 03:04 PM
Mulpas Joseph WVP & Chief Accounting OfficerAug 02Sale29.7812,000357,36012,587Aug 06 02:40 PM
Hightman Carrie JEVP & Chief Legal OfficerAug 02Sale29.9622,000659,120329,207Aug 06 02:38 PM
Disser Peter TVice President, AuditAug 02Sale29.9613,500404,4603,084Aug 06 02:36 PM
Jesanis Michael EDirectorAug 02Sale29.964,000119,84038,997Aug 06 02:35 PM
Brown Donald EugeneEVP & Chief Financial OfficerNov 08Sale26.182,40062,83246,767Nov 09 10:49 AM
GPRO GoPro, Inc. daily Stock Chart
GPRO [NASD]
GoPro, Inc.
Index- P/E- EPS (ttm)-0.22 Insider Own0.70% Shs Outstand139.28M Perf Week4.71%
Market Cap511.16M Forward P/E8.59 EPS next Y0.43 Insider Trans-81.30% Shs Float124.31M Perf Month-19.69%
Income-31.10M PEG- EPS next Q-0.48 Inst Own72.30% Short Float22.48% Perf Quarter-27.33%
Sales1.20B P/S0.43 EPS this Y0.00% Inst Trans8.68% Short Ratio5.01 Perf Half Y-42.92%
Book/sh1.36 P/B2.70 EPS next Y32.61% ROA-4.50% Target Price5.50 Perf Year-45.55%
Cash/sh0.93 P/C3.93 EPS next 5Y10.00% ROE-15.90% 52W Range3.25 - 7.64 Perf YTD-13.44%
Dividend- P/FCF- EPS past 5Y-33.20% ROI-27.10% 52W High-51.99% Beta0.99
Dividend %- Quick Ratio1.10 Sales past 5Y3.10% Gross Margin35.00% 52W Low12.92% ATR0.31
Employees891 Current Ratio1.60 Sales Q/Q3.40% Oper. Margin-1.30% RSI (14)39.73 Volatility6.98% 7.17%
OptionableYes Debt/Eq0.73 EPS Q/Q70.90% Profit Margin-2.60% Rel Volume0.43 Prev Close3.67
ShortableYes LT Debt/Eq0.73 EarningsOct 31 AMC Payout- Avg Volume5.57M Price3.67
Recom2.80 SMA20-13.89% SMA50-13.14% SMA200-32.62% Volume0 Change0.00%
Oct-03-19Reiterated Oppenheimer Outperform $9 → $7
Sep-26-18Upgrade Oppenheimer Perform → Outperform
Feb-05-18Reiterated Citigroup Neutral $7 → $5.50
Feb-02-18Downgrade JP Morgan Overweight → Neutral $8
Jan-23-18Downgrade Morgan Stanley Equal-Weight → Underweight
Jan-09-18Reiterated Wedbush Neutral $10.50 → $6
Jan-09-18Reiterated Dougherty & Company Sell $7 → $4
Jan-08-18Downgrade Longbow Buy → Neutral
Oct-18-17Upgrade Longbow Neutral → Buy
Oct-02-17Reiterated Dougherty & Company Sell $5 → $7
Aug-15-17Upgrade Goldman Sell → Neutral
Aug-04-17Upgrade Raymond James Underperform → Mkt Perform
Aug-04-17Upgrade Longbow Underperform → Neutral
Jul-31-17Upgrade Morgan Stanley Underweight → Equal-Weight
Mar-16-17Upgrade Citigroup Sell → Neutral
Mar-16-17Reiterated Stifel Hold $10 → $9
Mar-06-17Downgrade Goldman Neutral → Sell
Mar-03-17Initiated Citigroup Sell $8
Feb-03-17Reiterated Dougherty & Company Sell $6 → $5
Feb-03-17Downgrade Robert W. Baird Neutral → Underperform $10 → $6
Oct-15-19 04:05PM  GoPro Schedules Third Quarter 2019 Financial Results for November 7, 2019 PR Newswire
09:00AM  GoPro Kicks Off Million Dollar Challenge for HERO8 Black + MAX Camera Owners PR Newswire
Oct-11-19 11:51AM  GoPro stock gains after hedge fund boosts stake, Hero8 Black shipments start early MarketWatch +10.65%
09:01AM  GoPro Spikes as Hedge Fund Increases Stake, Hero8 Black Shipments Start Early TheStreet.com
06:30AM  GoPro Now Shipping HERO8 Black Cameras PR Newswire
Oct-10-19 09:19AM  Implied Volatility Surging for GoPro (GPRO) Stock Options Zacks
Oct-09-19 01:02PM  Two Gadget Makers Look to Move Manufacturing Out of China, Citing Trade War Bloomberg
11:53AM  Fitbit to Move Manufacturing of Smartwatch, Tracker Out of China Bloomberg
Oct-08-19 01:07PM  GPRO LOSSES ALERT: Bernstein Liebhard LLP Announces Investigation of GoPro, Inc. PR Newswire -7.03%
Oct-07-19 10:46PM  HAGENS BERMAN GPRO INVESTOR ALERT: Hagens Berman Investigating GoPro, Inc. (GPRO) for Possible Securities Fraud PR Newswire -6.80%
12:41PM  15 Most Popular Stocks Under $10, According To Robinhood Users Benzinga
Oct-04-19 03:47PM  Why GoPro Stock Deserves to Trade Below $5 InvestorPlace
12:17PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of GoPro, Inc. Investors Business Wire
Oct-03-19 08:01PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of GoPro, Inc. Investors Business Wire -19.01%
02:44PM  GoPro plunges after cutting outlook Yahoo Finance Video
12:55PM  GoPro Crashes 20% After Production Delay, Analysts Remain Cautious Benzinga
12:29PM  A Look At Benzinga Pro's Most-Searched Tickers For October 3, 2019 Benzinga
11:14AM  GoPro cuts outlook due to production delays Yahoo Finance Video
10:54AM  GoPro stock on track for its worst drop yet amid production delays for new Hero8 Black MarketWatch
10:52AM  GoPro Stock Is Tanking After the Company Cut Guidance. Even That May Be Too Optimistic. Barrons.com
10:47AM  Constellation weighed down by Canopy, Weak quarter at Bed Bath & Beyond, Uber launches marketplace for temps Yahoo Finance
07:07AM  Amid stock spike, GoPro has new cameras and something to say MarketWatch
03:26AM  PepsiCo, Tesla, Bed Bath, GoPro and Trade Uncertainty - 5 Things You Must Know TheStreet.com
Oct-02-19 06:52PM  GoPro shares plunge nearly 20% in extended trading on delay in camera shipments MarketWatch
06:30PM  UPDATE 1-GoPro cuts second-half outlook citing Hero8 shipment issues Reuters
06:17PM  Camera, Lights, Action! GoPro Introduces HERO8 BLACK, Mods and MAX - Redefining What's Possible with a Camera PR Newswire
06:05PM  GoPro cuts second-half outlook citing Hero8 shipment issues Reuters
02:56PM  [video]GoPro Slumps on Earnings Warning Tied to Production Delay of New Cameras TheStreet.com
08:57AM  KLA, GoPro, Canadian Solar, SolarEdge Technologies and JinkoSolar highlighted as Zacks Bull and Bear of the Day Zacks
06:45AM  Bear of the Day: GoPro (GPRO) Zacks
Oct-01-19 11:33AM  GoPro Rally Breaks Through 200-Day Moving Average Investopedia
10:19AM  GoPro stock surges after launch of new cameras MarketWatch
09:26AM  GoPro seeks holiday season action with two new cameras Reuters
09:05AM  GoPro unveils two action cameras ahead of holiday season Reuters
09:00AM  GoPro Management to Host Launch-Related Product and Financial Conference Call on October 2, 2019 PR Newswire
07:40AM  GoPro Shoots Higher as Action-Camera Maker Unveils New Products TheStreet.com
Sep-30-19 08:42AM  GoPro (GPRO) Looks Good: Stock Adds 7.4% in Session Zacks
Sep-29-19 08:04AM  GoPro, Inc. (NASDAQ:GPRO): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
Sep-27-19 05:04PM  GoPro Stock Soars on Heavy Volume, With No News Released Barrons.com +7.37%
12:00PM  GoPro's stock soars on heavy volume, with no news released MarketWatch
Sep-25-19 12:00PM  After A Big Sell-Off, A Low-Volume Rebound Means It's Time To Sell Stocks Investor's Business Daily
Sep-12-19 06:00AM  The Trade War Spurs Chinas Technology Innovators Into Overdrive Bloomberg
Sep-11-19 09:22AM  Owners of Apple Stock Should Be Afraid InvestorPlace
Sep-03-19 09:42AM  Would GoPro (NASDAQ:GPRO) Might Be Better Off With Less Debt Simply Wall St.
Aug-31-19 09:31AM  GoPro (GPRO) Down 23.1% Since Last Earnings Report: Can It Rebound? Zacks
Aug-30-19 03:14PM  GoPro: Tariff Proof, But This Upcoming Catalyst Is What Really Matters Benzinga
Aug-27-19 12:26PM  Edited Transcript of GPRO earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
07:30AM  GoPro (GPRO) Bullish on 2H19 Despite Tariff War Escalation Zacks
Aug-26-19 10:38AM  Legal Troubles Likely to Continue Haunting GoPro (GPRO) Stock: Morgan Stanley TipRanks
06:00AM  Tariffs Not Expected to Impact GoPro's Second Half 2019 Financial Performance PR Newswire
Aug-16-19 10:45AM  Motorola has GoPro aspirations for its latest budget handset TechCrunch
10:45AM  Investors Are Missing the Boat on GoPro Motley Fool
Aug-15-19 01:16PM  The 10 Biggest Losers from Q2 Earnings InvestorPlace
Aug-13-19 08:58AM  Bleak Near-Term Outlook for Audio Video Production Industry Zacks
Aug-10-19 07:00AM  GoPro Stock Gets a Large Investor as Shares Have Taken a Summer Slide Barrons.com
Aug-07-19 04:21PM  When Will GoPro (GPRO) Stock Hit Bottom? TipRanks
10:00AM  Where Will GoPro Be in 1 Year? Motley Fool
Aug-05-19 01:52PM  GoPro Inc (GPRO) Q2 2019 Earnings Call Transcript Motley Fool
Aug-02-19 04:57PM  Why GoPro Stock Dropped Today Motley Fool -12.72%
01:36PM  GoPro (GPRO) Misses Earnings and Revenue Estimates in Q2 Zacks
12:23PM  GoPro Feels Good About the Rest of the Year. Investors Arent So Sure. Barrons.com
11:17AM  Morgan Stanley Remains GoPro Bear; Wedbush Says It Could Turn Bullish Soon Benzinga
02:20AM  [video]GoPro Misses on Earnings, Gets Boost From Upbeat Outlook TheStreet.com
Aug-01-19 09:28PM  GoPro Swings to (Adjusted) Profitability, Promises a Stronger Second Half Motley Fool
07:35PM  GoPro (GPRO) Q2 Earnings and Revenues Lag Estimates Zacks
05:44PM  GoPro stock swings to gains after promising second-half rebound MarketWatch
04:25PM  UPDATE 1-GoPro misses profit estimates, shares fall 12% Reuters
04:10PM  GoPro lifts revenue forecast on new product slate, shares rebound Reuters
04:05PM  GoPro Announces Second Quarter 2019 Results PR Newswire
03:02PM  Predictable Nio Is Worth a Shot InvestorPlace
07:41AM  GoPro Q2 Earnings Preview Benzinga
Jul-31-19 09:00AM  It Takes Two to Make a Thing Go Right: GoPro and Quik Apps Combine for One Awesome Mobile Editing Experience PR Newswire
Jul-30-19 11:20AM  Sony (SNE) Q1 Earnings Beat Estimates, Revenues Fall Y/Y Zacks
09:25AM  GoPro (GPRO) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-29-19 04:37PM  Beyond Meat shares tank after announcing secondary offering Yahoo Finance
Jul-25-19 02:40PM  10 Heavily Shorted Stocks to Sell Because the Bears Are Right InvestorPlace
10:33AM  GoPro (GPRO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-24-19 09:40AM  Tile tracks down $45M as it expands beyond its location tags American City Business Journals
Jul-23-19 02:28PM  How to Find Buy-Ranked Stocks Under $10 Zacks
Jul-18-19 05:30PM  These 3 Charts Show Why GoPro's Comeback Will Be Challenging Motley Fool
04:05PM  GoPro Schedules Second Quarter 2019 Financial Results for August 1, 2019 PR Newswire
09:30AM  Has GoPro (GPRO) Outpaced Other Consumer Discretionary Stocks This Year? Zacks
09:30AM  How to shoot your next adventure like a pro Engadget
Jul-17-19 09:26AM  GoPro, Inc. (NASDAQ:GPRO) Insiders Have Been Selling Simply Wall St.
Jul-12-19 07:00AM  3 Zacks Rank #1 Growth Stocks Zacks
Jul-10-19 11:33AM  The 5 Best Stocks to Invest in Self-Driving Cars InvestorPlace
Jul-09-19 05:45PM  Is GoPro Stock a Buy? Motley Fool
Jul-02-19 12:14PM  Explosive Stocks Under $10 Zacks
Jul-01-19 09:30AM  Is GoPro (GPRO) Outperforming Other Consumer Discretionary Stocks This Year? Zacks
Jun-27-19 05:45PM  GoPro (GPRO) Stock Sinks As Market Gains: What You Should Know Zacks
Jun-25-19 10:44AM  Top 5 Shareholders of GoPro (GPRO) Investopedia
09:35AM  Can Sinking GoPro Stock Record a Turnaround? Investopedia
Jun-24-19 09:31AM  Better Contrarian Play: GoPro or Fitbit? Motley Fool
Jun-21-19 05:45PM  GoPro (GPRO) Flat As Market Sinks: What You Should Know Zacks
Jun-19-19 09:21AM  GoPro Tries the Subscription Angle Motley Fool
Jun-18-19 09:00AM  GoPro Enhances PLUS Subscription Service at GoPro.com PR Newswire
Jun-17-19 09:10AM  Retail Sales Data Shows Surge in Consumer Spending: 5 Picks Zacks
Jun-14-19 05:45PM  GoPro (GPRO) Dips More Than Broader Markets: What You Should Know Zacks
Jun-13-19 09:30AM  Is GoPro (GPRO) Stock Outpacing Its Consumer Discretionary Peers This Year? Zacks
Jun-12-19 09:56AM  Google is moving Nest, server motherboard manufacturing out of China amid Trump trade war American City Business Journals
GoPro, Inc. develops and sells cameras, drones, and mountable and wearable accessories in the United States and internationally. The company offers HERO7, a cloud-connected line of camera; Fusion, a waterproof spherical camera; GoPro Plus, a cloud-based storage solution that enables subscribers to access, edit, and share content; Quik, a mobile editing app, as well as desktop app for editing options for power users; GoPro App, a mobile app that allows users to preview and play back photos and videos, control GoPro cameras, and share content; and Karma Grip, a handheld or body-mountable camera stabilizer that capture zero-shake smooth video. It also offers mounts and accessories comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and tripod mounts that enable consumers to wear the mount on their bodies, such as wrist housings, chest harnesses, and head straps. GoPro, Inc. markets and sells its products through retailers and wholesale distributors, as well as through its Website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2004 and is headquartered in San Mateo, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCGEE BRIANEVP, Chief Financial OfficerSep 03Sale3.835,45120,877157,620Sep 05 05:54 PM
Ahmad-Taylor TyroneDirectorAug 05Sale4.354,18918,22228,510Aug 07 04:13 PM
Woodman NicholasCEO, Chairman of the BoardJul 01Sale5.34700,0003,735,6200Jul 02 04:19 PM
Woodman NicholasCEO, Chairman of the BoardJun 28Sale5.48700,0003,838,1000Jul 02 04:19 PM
Woodman NicholasCEO, Chairman of the BoardMay 29Sale6.67700,0004,669,8400May 30 04:30 PM
Woodman NicholasCEO, Chairman of the BoardMay 28Sale6.88700,0004,819,0800May 30 04:30 PM
Barna SandorSVP, Chief Technology OfficerMay 15Sale7.4921,642162,099167,581May 17 05:11 PM
Ahmad-Taylor TyroneDirectorMay 13Sale6.438,37853,8814,189May 15 05:18 PM
Woodman NicholasCEO, Chairman of the BoardMay 01Sale5.91342,6792,026,1920May 01 07:20 PM
Woodman NicholasCEO, Chairman of the BoardApr 30Sale5.92506,4762,998,4390May 01 07:20 PM
Woodman NicholasCEO, Chairman of the BoardApr 29Sale6.02550,8453,316,9680May 01 07:20 PM
Woodman NicholasCEO, Chairman of the BoardMar 29Sale6.47726,9564,706,0220Apr 01 05:35 PM
Woodman NicholasCEO, Chairman of the BoardMar 28Sale6.57673,0444,419,0050Apr 01 05:35 PM
Woodman NicholasCEO, Chairman of the BoardMar 01Sale6.04660,0513,987,0380Mar 04 07:31 PM
Woodman NicholasCEO, Chairman of the BoardFeb 28Sale5.85739,9494,325,8900Mar 04 07:31 PM
MCGEE BRIANEVP, Chief Financial OfficerFeb 20Sale6.0419,526117,96468,262Feb 20 05:30 PM
Ahmad-Taylor TyroneDirectorNov 19Sale5.444,18822,79012,567Nov 19 04:59 PM
MCGEE BRIANEVP, Chief Financial OfficerNov 16Sale5.362,45313,14899,209Nov 19 02:41 PM
CMRX Chimerix, Inc. daily Stock Chart
CMRX [NASD]
Chimerix, Inc.
Index- P/E- EPS (ttm)-1.32 Insider Own17.50% Shs Outstand64.45M Perf Week-7.93%
Market Cap97.32M Forward P/E- EPS next Y-1.10 Insider Trans0.70% Shs Float50.41M Perf Month-36.02%
Income-66.40M PEG- EPS next Q-0.22 Inst Own68.10% Short Float1.28% Perf Quarter-58.63%
Sales9.00M P/S10.81 EPS this Y5.40% Inst Trans0.33% Short Ratio1.45 Perf Half Y-42.15%
Book/sh2.92 P/B0.52 EPS next Y-0.90% ROA-36.30% Target Price5.00 Perf Year-59.08%
Cash/sh2.46 P/C0.61 EPS next 5Y- ROE-39.00% 52W Range1.42 - 4.40 Perf YTD-41.25%
Dividend- P/FCF- EPS past 5Y17.10% ROI-40.50% 52W High-65.68% Beta1.48
Dividend %- Quick Ratio11.70 Sales past 5Y10.60% Gross Margin- 52W Low6.34% ATR0.13
Employees82 Current Ratio11.70 Sales Q/Q16.70% Oper. Margin- RSI (14)25.72 Volatility6.55% 6.79%
OptionableYes Debt/Eq0.00 EPS Q/Q11.30% Profit Margin- Rel Volume0.77 Prev Close1.51
ShortableYes LT Debt/Eq0.00 EarningsNov 07 BMO Payout- Avg Volume443.64K Price1.51
Recom2.50 SMA20-25.14% SMA50-31.89% SMA200-43.90% Volume0 Change0.00%
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Feb-02-18Initiated H.C. Wainwright Buy $10
Aug-09-16Reiterated FBR Capital Mkt Perform $9 → $8
Feb-23-16Reiterated FBR Capital Mkt Perform $14 → $10
Feb-23-16Downgrade Morgan Stanley Equal-Weight → Underweight
Feb-23-16Downgrade Barclays Overweight → Equal Weight $12 → $6
Feb-22-16Downgrade Citigroup Buy → Neutral
Dec-29-15Downgrade JP Morgan Overweight → Neutral $65 → $15
Dec-28-15Reiterated Piper Jaffray Overweight $63 → $10
Dec-28-15Downgrade FBR Capital Outperform → Mkt Perform $73 → $14
Dec-17-15Initiated UBS Buy $55
Oct-05-15Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-03-15Initiated Citigroup Buy
Aug-18-15Initiated FBR Capital Outperform $73
Aug-06-15Reiterated Brean Capital Buy $50 → $57
May-11-15Reiterated Brean Capital Buy $45 → $50
Mar-04-15Initiated Barclays Overweight $55
Feb-12-15Reiterated Stifel Buy $47 → $57
Dec-31-14Reiterated Brean Capital Buy $33 → $45
Jul-08-14Resumed Brean Capital Buy $33
Oct-02-19 08:47AM  Have Insiders Been Buying Chimerix, Inc. (NASDAQ:CMRX) Shares? Simply Wall St.
Oct-01-19 08:10AM  The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines Benzinga -13.62%
Sep-30-19 07:30PM  Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir GlobeNewswire -6.00%
Sep-27-19 08:00AM  Chimerix to Present at 2019 Cantor Global Healthcare Conference GlobeNewswire
Aug-27-19 01:13PM  Those Who Purchased Chimerix (NASDAQ:CMRX) Shares Five Years Ago Have A 91% Loss To Show For It Simply Wall St.
Aug-08-19 09:35AM  Chimerix (CMRX) Reports Q2 Loss, Lags Revenue Estimates Zacks
08:00AM  Chimerix Announces Second Quarter 2019 Financial Results and Operational Update GlobeNewswire
Aug-07-19 10:30AM  Chimerix (CMRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
Aug-05-19 07:55AM  Durham pharma spends $30 million for rights to potential Leukemia treatment American City Business Journals -11.52%
Jul-31-19 07:00AM  Chimerix Announces Exclusive Worldwide License of Phase 3 Ready CX-01 for Development in Acute Myeloid Leukemia GlobeNewswire
Jul-12-19 03:07PM  Do Institutions Own Chimerix, Inc. (NASDAQ:CMRX) Shares? Simply Wall St.
Jun-28-19 06:41PM  Did Hedge Funds Drop The Ball On Chimerix Inc (CMRX) ? Insider Monkey +19.01%
May-17-19 08:18AM  Edited Transcript of CMRX earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-16-19 09:11AM  Will Chimerix to Surge Higher? Zacks
May-09-19 09:25AM  Chimerix (CMRX) Reports Q1 Loss, Tops Revenue Estimates Zacks +7.49%
08:25AM  Chimerix: 1Q Earnings Snapshot Associated Press
08:00AM  Chimerix Announces First Quarter 2019 Financial Results and Strategy Update GlobeNewswire
06:30AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
May-02-19 04:01PM  Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019 GlobeNewswire
Apr-29-19 10:31AM  Will Chimerix (CMRX) Report Negative Q1 Earnings? What You Should Know Zacks +6.20%
Apr-12-19 01:43PM  One Thing To Remember About The Chimerix, Inc. (NASDAQ:CMRX) Share Price Simply Wall St. -7.24%
Apr-09-19 11:21AM  Chimerix taps former Endocyte executive as new CEO American City Business Journals +31.10%
08:10AM  The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing Benzinga
Apr-08-19 05:00PM  Chimerix Announces Management Updates GlobeNewswire
Apr-05-19 02:14PM  Again, Durham pharma loses a drug development partner American City Business Journals
Mar-26-19 06:30PM  Edited Transcript of CMRX earnings conference call or presentation 5-Mar-19 1:30pm GMT Thomson Reuters StreetEvents +7.43%
Mar-07-19 12:24PM  Should You Be Worried About Insider Transactions At Chimerix, Inc. (NASDAQ:CMRX)? Simply Wall St.
Mar-05-19 07:00AM  Chimerix Announces Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire -16.09%
Mar-04-19 08:00AM  Chimerix to Present at Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-26-19 08:00AM  Chimerix to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019 GlobeNewswire
Feb-22-19 08:00AM  Chimerix Presents Results from Post-hoc Analysis of Phase 3 Study GlobeNewswire
Feb-14-19 08:15AM  Chimerix filing reveals ex-CEO's severance package after sudden resignation American City Business Journals -7.08%
Feb-11-19 07:55AM  New Research Coverage Highlights United Parcel Service, Healthcare Trust of America, CommVault, SPX FLOW, Chimerix, and International Speedway Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Feb-06-19 02:20PM  Sudden Departure: Chimerix CEO, board member resigns American City Business Journals
08:00AM  Chimerix Announces Management Transition GlobeNewswire
Jan-30-19 11:51AM  What Type Of Shareholder Owns Chimerix, Inc.s (NASDAQ:CMRX)? Simply Wall St. +11.68%
Jan-24-19 10:17AM  Will Overall Growth Aid Thermo Fisher's (TMO) Q4 Earnings? Zacks
10:03AM  Can Solid Consumables Drive Illumina's (ILMN) Q4 Earnings? Zacks
Jan-18-19 06:36AM  What Lies Ahead for Abbott (ABT) Stock This Earnings Season? Zacks -6.57%
Jan-17-19 09:38AM  4 Medical Product Stocks Likely to Top Q4 Earnings Estimates Zacks
Jan-04-19 07:30AM  Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.14%
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals +6.52%
Dec-22-18 04:43AM  Should You Avoid Chimerix Inc (CMRX)? Insider Monkey
Dec-18-18 08:35AM  5 Beaten-Down Medical Product Stocks to Rebound in 2019 Zacks
Dec-12-18 11:26AM  Is Chimerix, Inc. (NASDAQ:CMRX) Overpaying Its CEO? Simply Wall St.
Dec-03-18 07:55AM  New Research: Key Drivers of Growth for Q2, BioTime, Verastem, Fair Isaac, Ulta Beauty, and Chimerix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-08-18 07:44AM  Chimerix: 3Q Earnings Snapshot Associated Press
07:00AM  Chimerix Announces Third Quarter 2018 Financial Results GlobeNewswire
Nov-07-18 08:14AM  Chimerix to Present at the Stifel 2018 Healthcare Conference GlobeNewswire
Nov-05-18 02:29PM  The most valuable public companies in the Triangle (Slideshow) American City Business Journals
Nov-01-18 08:00AM  Chimerix to Announce Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire
Oct-27-18 01:00PM  Chimerix Presents Preclinical Data Demonstrating Antiviral Activity of Brincidofovir Against Polyomavirus at Kidney Week 2018 GlobeNewswire
Oct-24-18 07:25AM  Report: Developing Opportunities within Univar, Aqua America, Chimerix, Superior Energy Services, TechTarget, and ZIOPHARM Oncology Future Expectations, Projections Moving into 2018 GlobeNewswire -8.05%
Oct-11-18 04:01PM  Chimerix to Host Annual Investor Update on October 17, 2018 GlobeNewswire
01:23PM  How Should You Think About Chimerix Incs (NASDAQ:CMRX) Risks? Simply Wall St.
Oct-05-18 07:00AM  Chimerix Presents Results from Multiple Ascending Dose Study of IV Brincidofovir at IDWeek GlobeNewswire
Oct-04-18 07:00AM  Landmark AdVance Study Shows Adenovirus Burden Correlates with Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients GlobeNewswire
Sep-26-18 07:30AM  Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-04-18 02:38PM  Inside The List: Highest-Paid Public Company CEOs American City Business Journals
Aug-29-18 07:00AM  Chimerix to Participate in September Investor Conferences GlobeNewswire
Aug-28-18 07:30AM  Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-08-18 09:50AM  Chimerix (CMRX) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:43AM  Chimerix: 2Q Earnings Snapshot Associated Press
07:00AM  Chimerix Announces Second Quarter 2018 Financial Results GlobeNewswire
06:30AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 08:00AM  Chimerix to Announce Second Quarter 2018 Financial Results on August 8, 2018 GlobeNewswire
Jun-29-18 07:35AM  New Research: Key Drivers of Growth for Webster Financial, Chimerix, Commerce Bancshares, Teligent, Pinnacle Financial Partners, and Empire State Realty Trust Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-12-18 07:00AM  Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New Antiviral for Treatment and Prevention of Norovirus GlobeNewswire
Jun-10-18 05:29PM  The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs Benzinga
Jun-08-18 02:17PM  What new FDA designation means for Durham's Chimerix American City Business Journals
Jun-07-18 08:41AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:30AM  Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox GlobeNewswire
Jun-05-18 05:29PM  Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) GlobeNewswire
May-17-18 08:20AM  Recent Analysis Shows Camden Property Trust, Biglari, Argan, Chimerix, Workhorse Group, and Magellan Midstream Partners Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-10-18 01:45AM  Edited Transcript of CMRX earnings conference call or presentation 7-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-07-18 10:27AM  Want To Invest In Chimerix Inc (NASDAQ:CMRX)? Heres How It Performed Lately Simply Wall St.
07:29AM  Chimerix: 1Q Earnings Snapshot Associated Press
07:00AM  Chimerix Announces First Quarter 2018 Financial Results GlobeNewswire
06:30AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
May-02-18 08:00AM  Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference GlobeNewswire
Apr-30-18 08:00AM  Chimerix to Announce First Quarter 2018 Financial Results on May 7, 2018 GlobeNewswire -7.47%
Apr-02-18 08:00AM  Chimerix to Present at the H.C. Wainwright Annual Global Life Sciences Conference GlobeNewswire -6.92%
Mar-30-18 03:11PM  Look what Triangle woman just became chairwoman of a $250M company American City Business Journals
Mar-29-18 04:30PM  Chimerix Announces Martha J. Demski as Board Chair; Appoints New Members to Board of Directors GlobeNewswire
Mar-23-18 08:48AM  Durham pharma pushing to fight a common cold virus that's deadly to some patients American City Business Journals
Mar-19-18 07:00AM  The AdVance Study: a Landmark Natural History Study of Adenovirus in Allogeneic Hematopoietic Cell Transplant Shows Strong Correlation Between Disease Burden and Mortality Risk GlobeNewswire
Mar-07-18 08:00AM  Chimerix to Present at Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-06-18 09:47AM  Chimerix Q4 Loss Narrower Than Expected, Revenues Exceed Zacks
Mar-02-18 07:35AM  New Research: Key Drivers of Growth for Corcept Therapeutics, HubSpot, Tableau Software, Balchem, Steelcase, and Chimerix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-01-18 08:16PM  Edited Transcript of CMRX earnings conference call or presentation 1-Mar-18 1:30pm GMT Thomson Reuters StreetEvents
08:13AM  Chimerix reports 4Q loss Associated Press
07:00AM  Chimerix Announces Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
06:55AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
Feb-22-18 08:00AM  Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018 GlobeNewswire
Feb-15-18 07:39AM  Could These 2 Biotech Stocks Really Double Your Money? Motley Fool
Jan-08-18 07:00AM  Wired News Chimerix Announced Initiation of AdAPT Study for Oral Brincidofovir and Advancement of IV Brincidofovir to Phase-2 Studies ACCESSWIRE
Jan-05-18 08:20AM  Recent Analysis Shows Chimerix, Highwoods Properties, HubSpot, Biglari, IDEXX Laboratories, and Argan Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
07:00AM  Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies GlobeNewswire
Jan-03-18 04:01PM  Chimerix to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 11:57AM  ETFs with exposure to Chimerix, Inc. : December 28, 2017 Capital Cube
Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines that address unmet medical needs in the United States. The company's lead product candidate is brincidofovir, an investigational nucleoside analog for the prevention of viral infections in hematopoietic or stem cell transplant recipients (HCT), as well as for the treatment of adenovirus infection and disease, smallpox, and BK virus infection in kidney and HCT transplant recipients. It is also developing CMX521, a nucleoside for the treatment of norovirus; and CMX157, a nucleoside analog for the treatment of HIV and hepatitis B virus infection. Chimerix, Inc. has license agreements with ContraVir Pharmaceuticals for the development and commercialization of CMX157 for various antiviral indications; Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; and Cantex Pharmaceuticals, Inc. for the development and commercialization of CX-01, a heparin derivative that is used in the treatment of acute myeloid leukemia and other serious diseases. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DEMSKI MARTHA JDirectorMay 28Buy3.6018,00064,80037,013May 29 12:29 PM
Sherman Michael A.Chief Executive OfficerMay 20Buy3.4830,000104,31630,000May 20 04:36 PM
MIDDLETON FRED ADirectorMay 10Buy2.9230,00087,67897,523May 13 05:21 PM
ESPR Esperion Therapeutics, Inc. daily Stock Chart
ESPR [NASD]
Esperion Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.04 Insider Own0.50% Shs Outstand26.17M Perf Week10.20%
Market Cap1.02B Forward P/E- EPS next Y-3.80 Insider Trans112.72% Shs Float25.25M Perf Month6.06%
Income-76.80M PEG- EPS next Q-1.95 Inst Own- Short Float19.92% Perf Quarter-11.72%
Sales146.40M P/S6.97 EPS this Y-8.10% Inst Trans0.51% Short Ratio12.00 Perf Half Y-2.72%
Book/sh4.80 P/B8.13 EPS next Y-33.80% ROA-35.60% Target Price81.38 Perf Year-13.20%
Cash/sh11.51 P/C3.39 EPS next 5Y28.30% ROE-59.60% 52W Range33.13 - 60.99 Perf YTD-15.20%
Dividend- P/FCF- EPS past 5Y-17.90% ROI- 52W High-36.04% Beta1.83
Dividend %- Quick Ratio5.70 Sales past 5Y- Gross Margin- 52W Low17.75% ATR1.45
Employees76 Current Ratio5.70 Sales Q/Q- Oper. Margin- RSI (14)58.98 Volatility3.70% 3.73%
OptionableYes Debt/Eq0.00 EPS Q/Q-17.80% Profit Margin-52.50% Rel Volume0.57 Prev Close39.01
ShortableYes LT Debt/Eq0.00 EarningsNov 07 BMO Payout- Avg Volume419.30K Price39.01
Recom1.80 SMA204.96% SMA505.18% SMA200-10.10% Volume0 Change0.00%
Sep-16-19Upgrade Goldman Sell → Neutral $55 → $45
May-29-19Downgrade Goldman Neutral → Sell
May-06-19Upgrade BofA/Merrill Underperform → Neutral
Apr-26-19Upgrade Goldman Sell → Neutral $50
Mar-13-19Upgrade JP Morgan Underweight → Neutral $38 → $47
Jan-07-19Reiterated Needham Strong Buy $94 → $114
Dec-13-18Initiated Goldman Sell $45
Oct-29-18Upgrade Northland Capital Market Perform → Outperform
Oct-16-18Initiated BTIG Research Buy $82
Aug-17-18Upgrade Citigroup Neutral → Buy
Jul-11-18Downgrade Northland Capital Outperform → Market Perform
May-03-18Downgrade JP Morgan Neutral → Underweight $41
May-02-18Downgrade BofA/Merrill Buy → Underperform
Mar-27-18Reiterated Chardan Capital Markets Neutral $75 → $100
Feb-21-18Reiterated Needham Strong Buy $81 → $94
Jan-22-18Downgrade Citigroup Buy → Neutral
Jan-18-18Initiated Credit Suisse Outperform $103
Jan-17-18Reiterated UBS Buy $62 → $88
Jan-05-18Upgrade BofA/Merrill Neutral → Buy
Dec-14-17Upgrade Needham Buy → Strong Buy $72 → $81
Oct-04-19 08:34AM  Here's Why We're Not At All Concerned With Esperion Therapeutics's (NASDAQ:ESPR) Cash Burn Situation Simply Wall St.
Sep-09-19 10:57AM  7 Micro-Cap and Small-Cap Stocks That Insiders Are Buying InvestorPlace
Sep-07-19 09:30AM  Esperion Therapeutics (ESPR) Down 10.8% Since Last Earnings Report: Can It Rebound? Zacks
Sep-06-19 06:15PM  Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $259,125 of Shares GuruFocus.com
Aug-30-19 04:15PM  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
10:26AM  Esperion's Bempedoic Acid Succeeds in Phase II Diabetes Study Zacks
Aug-29-19 07:30AM  Esperion Announces Positive Top-Line Results from Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Tablet in Patients with Hypercholesterolemia and Type 2 Diabetes GlobeNewswire
Aug-26-19 11:05AM  Esperion's Drugs in Review Hold Potential, Funds a Concern Zacks
Aug-20-19 11:15AM  Does Market Volatility Impact Esperion Therapeutics, Inc.'s (NASDAQ:ESPR) Share Price? Simply Wall St.
Aug-09-19 08:06AM  Esperion (ESPR) Q2 Loss Wider Than Expected, Revenues Beat Zacks
Aug-08-19 09:15AM  Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:30AM  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter Financial Results GlobeNewswire
Aug-06-19 04:15PM  Esperion to Present at the BTIG Biotechnology Conference GlobeNewswire
Aug-02-19 07:15PM  Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $197,800 of Shares GuruFocus.com
Jul-31-19 01:48PM  Steven Cohen Charges Into Chiasma GuruFocus.com
Jul-30-19 04:15PM  Esperion to Report Second Quarter 2019 Financial Results August 8, 2019 GlobeNewswire
03:16PM  A Firm's First Profit Can Mean Big Returns for Investors Zacks
Jul-29-19 08:08AM  3 Biotech Stocks Corporate Insiders are Buying TipRanks
Jul-07-19 07:10PM  Weekly CEO Buys Highlight GuruFocus.com
Jul-05-19 12:25PM  Is Esperion Therapeutics, Inc. (ESPR) A Good Stock To Buy? Insider Monkey
Jun-26-19 04:10PM  Esperion and Oberland Capital Announce $200 Million Funding Agreement GlobeNewswire
Jun-19-19 10:40AM  Have Insiders Been Buying Esperion Therapeutics, Inc. (NASDAQ:ESPR) Shares This Year? Simply Wall St.
Jun-07-19 09:30AM  Esperion Therapeutics (ESPR) Down 5.6% Since Last Earnings Report: Can It Rebound? Zacks
May-30-19 04:15PM  Esperion Announces the Appointment of Tracy M. Woody to Board of Directors GlobeNewswire
May-29-19 04:23PM  Biotech Stocks Clobbered As Two Slammed With Sell Ratings Investor's Business Daily
May-28-19 07:00AM  Esperion to Participate in Upcoming Investor Conferences GlobeNewswire
May-27-19 06:00AM  Esperion Aims for the First Approved Non-Statin Cholesterol Reducer MoneyShow
May-10-19 08:00AM  Esperion to Participate in Upcoming Investor Conferences GlobeNewswire
May-09-19 06:00AM  Esperion Gets a Go-Ahead from the FDA MoneyShow
May-08-19 08:35AM  Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Surpass Estimates Zacks
07:25AM  Esperion Therapeutics: 1Q Earnings Snapshot Associated Press
07:00AM  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports First Quarter Financial Results GlobeNewswire
May-07-19 05:30AM  Esperion to Host Analyst and Investor Day Event on May 30 GlobeNewswire
May-06-19 04:15PM  A Single Rival Caused 2 Biopharma Stocks To Slip Here's Why Investor's Business Daily +11.56%
01:30PM  Here's Why Esperion Therapeutics Shares Rocketed 11.5% Higher Today Motley Fool
10:33AM  Small-Cap Biotech Esperion Surges On FDA Acceptance Of Cholesterol Drug Applications Benzinga
May-05-19 05:00PM  Esperion Announces U.S. FDA Acceptance of New Drug Applications (NDAs) for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet for Filing and Regulatory Review GlobeNewswire
May-02-19 02:41PM  Heres What Hedge Funds Think About Esperion Therapeutics, Inc. (ESPR) Insider Monkey
Apr-24-19 02:12PM  Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors to Contact Law Firm for Possible Claims Against Officers and Directors PR Newswire
Apr-07-19 10:45PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-02-19 04:30PM  Esperion to Present at the Needham & Company 18th Annual Healthcare Conference GlobeNewswire +8.04%
Apr-01-19 07:15PM  Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $200,000 of Shares GuruFocus.com
04:15PM  Esperion Announces Publication in The Journal of the American Heart Association of Bempedoic Acid Study 3 Results GlobeNewswire
Mar-30-19 09:30AM  Esperion Therapeutics (ESPR) Down 12.9% Since Last Earnings Report: Can It Rebound? Zacks
Mar-21-19 07:15PM  Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $217,400 of Shares GuruFocus.com
Mar-18-19 09:20AM  Esperion Announces Late-Breaking Presentation of Final Results of Bempedoic Acid Pivotal Phase 3 Study 2 at the American College of Cardiology 2019 Scientific Sessions GlobeNewswire
Mar-14-19 09:15PM  Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $243,650 of Shares GuruFocus.com -8.47%
Mar-13-19 05:05PM  Esperion Announces Publication of Bempedoic Acid Study 1 Results in The New England Journal of Medicine GlobeNewswire +7.55%
Mar-12-19 07:19AM  Did You Miss Esperion Therapeuticss (NASDAQ:ESPR) Impressive 225% Share Price Gain? Simply Wall St.
Mar-05-19 08:25AM  New Research Coverage Highlights Advance Auto Parts, AxoGen, Encana, Federal Signal, Nelnet, and Esperion Therapeutics Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Mar-04-19 04:30PM  Esperion to Participate in Upcoming Investor Conferences GlobeNewswire
08:00AM  Esperion Announces Presentation of Bempedoic Acid Pivotal Phase 3 Study 2 Results in a Late-Breaking Clinical Trial Session at the American College of Cardiology 2019 Scientific Sessions GlobeNewswire
Mar-01-19 09:39AM  Esperion (ESPR) Reports Wider-Than-Expected Loss in Q4 Zacks
Feb-28-19 04:30PM  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
07:00AM  Esperion Announces Submissions of Two NDAs and Official Completion of Two MAA Validations for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet GlobeNewswire
Feb-22-19 05:30PM  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire +5.39%
Jan-29-19 08:45AM  Update in Lawsuit for Investors in NASDAQ: ESPR shares against Esperion Therapeutics, Inc. announced by Shareholders Foundation GlobeNewswire
Jan-11-19 09:16AM  For Esperion Therapeutics, 2019 Could Be a Big Year Motley Fool
Jan-07-19 07:15AM  Update: Lawsuit for Investors in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) announced by Shareholders Foundation ACCESSWIRE
02:00AM  Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet PR Newswire
Jan-06-19 10:00AM  All the Pre-JPM News Healthcare Investors Need to Know Motley Fool
Jan-04-19 04:34PM  Why Arcus Biosciences, Eldorado Gold, and Esperion Therapeutics Slumped Today Motley Fool -6.12%
07:20AM  Esperion to receive $300 million in upfront payments in deal with Daiichi Sankyo MarketWatch
07:00AM  Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to Commercialize Bempedoic Acid in Europe GlobeNewswire
Jan-02-19 04:15PM  Esperion to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-19-18 10:28PM  Is Esperion Therapeutics, Inc. (ESPR) A Good Stock To Buy? Insider Monkey
Nov-14-18 08:52AM  Do Options Traders Know Something About Esperion (ESPR) Stock We Don't? Zacks -7.42%
Nov-10-18 08:15AM  Esperion Announces Late-Breaking Oral Presentation of Final Study 3 Results (1002-046) of Bempedoic Acid at the American Heart Association Scientific Sessions 2018 GlobeNewswire
Nov-09-18 07:50AM  Report: Exploring Fundamental Drivers Behind American Vanguard, Pioneer Natural Resources, American States Water, Groupon, Esperion Therapeutics, and Paylocity Holding New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire -6.79%
Nov-08-18 08:44AM  What's Next for Esperion Therapeutics' Cholesterol-Lowering Drug Motley Fool
08:00AM  Esperion to Participate in Upcoming Investor Conferences GlobeNewswire
06:00AM  3 Biotech Stocks Poised for Big Rebounds Investopedia
Nov-01-18 04:05PM  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2018 Financial Results GlobeNewswire +9.93%
Oct-31-18 02:27PM  Esperion CEO on safety of new cholesterol drug CNBC Videos +6.44%
Oct-29-18 07:43AM  Esperion stock surges 15% on late-stage results for cholesterol drug MarketWatch
Oct-28-18 05:10PM  Esperion Announces Completion of Phase 3 LDL-C Lowering Development Program of Bempedoic Acid and Positive Cumulative Results GlobeNewswire
05:00PM  Esperion Announces Positive Top-Line Results from Final Pivotal Phase 3 Study of Bempedoic Acid GlobeNewswire
Oct-26-18 08:00AM  Today's Research Reports on Trending Tickers: Gilead Sciences, Inc. and Esperion Therapeutics, Inc. ACCESSWIRE +13.22%
Oct-20-18 07:01AM  3 Top Healthcare Stocks to Buy in October Motley Fool
Oct-18-18 05:00PM  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Oct-17-18 08:10AM  New Research Coverage Highlights Esperion Therapeutics, Summit Therapeutics, Ocwen Financial, Keane Group, Cellectis S.A, and Rapid7 Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-09-18 08:45AM  Do Options Traders Know Something About Esperion (ESPR) Stock We Don't? Zacks
Sep-13-18 08:52AM  Are Options Traders Betting on a Big Move in Esperion (ESPR) Stock? Zacks
Sep-02-18 09:33AM  3 Biotech Stocks That Could Soar in September Motley Fool
Aug-28-18 10:27AM  Esperion (ESPR) Combination Regimen Lowers Bad Cholesterol Zacks
Aug-27-18 10:22AM  Esperion's combo therapy lowers cholesterol level by 35 pct, shares surge Reuters
08:11AM  Esperion announces positive results for cholesterol-lowering therapy MarketWatch
07:32AM  Esperion says combo therapy lowers cholesterol level by 35 pct Reuters
07:00AM  Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Bempedoic Acid / Ezetimibe Combination Pill Study GlobeNewswire
Aug-26-18 03:40PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results Benzinga
Aug-25-18 05:45AM  Esperion Announces Late-Breaking Oral Presentation of Final Results of Phase 3 Long-Term Safety Study of Bempedoic Acid at the European Society of Cardiology Congress GlobeNewswire
Aug-23-18 08:42AM  Are Options Traders Betting on a Big Move in Esperion (ESPR) Stock? Zacks
Aug-20-18 07:45AM  Market Trends Toward New Normal in Esperion Therapeutics, Oxford Immunotec Global, Limoneira, R1 RCM, Carbonite, and Shenandoah Telecommunications Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Aug-19-18 12:00PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Earnings Benzinga
Aug-13-18 09:00PM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Aug-10-18 04:30PM  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-02-18 07:51AM  Esperion Therapeutics: 2Q Earnings Snapshot Associated Press +6.64%
07:00AM  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-16-18 07:45AM  Insider Buys Of The Week: Energen, Esperion Therapeutics And International Flavors Benzinga
Jul-10-18 08:55AM  Options Traders Expect Huge Moves in Esperion Therapeutics (ESPR) Stock Zacks -5.27%
Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its lead product candidate is bempedoic acid/ezetimibe combination tablet, a non-statin, orally available, LDL-C lowering therapy for patients with hypercholesterolemia and with atherosclerotic cardiovascular disease, and/or heterozygous familial hypercholesterolemia that is in Phase III long-term safety and tolerability study. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was founded in 2008 and is headquartered in Ann Arbor, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MAYLEBEN TIMOTHY MPresident & CEOSep 06Buy35.252,50088,12578,663Sep 06 04:22 PM
MAYLEBEN TIMOTHY MPresident & CEOSep 04Buy34.205,000170,98276,163Sep 06 04:22 PM
BIOTECH TARGET N V10% OwnerSep 04Buy33.7880,0002,702,2083,652,964Sep 06 04:09 PM
MAYLEBEN TIMOTHY MPresident & CEOAug 01Buy39.565,000197,80071,163Aug 02 04:06 PM
BIOTECH TARGET N V10% OwnerJul 23Buy42.6550,0002,132,5653,572,964Jul 25 12:42 PM
MAYLEBEN TIMOTHY MPresident & CEOJun 28Buy46.005,000230,00066,163Jul 01 04:57 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 29Buy40.005,000200,00061,163Apr 01 04:41 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 20Buy43.485,000217,40056,163Mar 21 05:01 PM
VITULLO NICOLEDirectorMar 19Sale44.7315,329685,5960Mar 21 09:02 AM
MAYLEBEN TIMOTHY MPresident & CEOMar 14Buy48.735,000243,65051,163Mar 14 04:57 PM
BIOTECH TARGET N V10% OwnerMar 14Buy49.8950,0002,494,3553,522,964Mar 15 07:50 PM
NEWTON ROGER SDirectorMar 12Sale50.0625,0001,251,500548,726Mar 14 04:57 PM
BIOTECH TARGET N V10% OwnerJan 04Buy41.2980,0003,303,2563,472,964Jan 07 05:10 PM
BIOTECH TARGET N V10% OwnerDec 24Buy39.9150,0001,995,7253,392,964Dec 26 11:44 AM
BIOTECH TARGET N V10% OwnerDec 17Buy47.7360,0002,864,0703,342,964Dec 19 01:14 PM
Boxer Capital, LLC10% OwnerNov 05Sale57.1660,0003,429,8431,101,250Nov 05 07:56 PM
Boxer Capital, LLC10% OwnerNov 02Sale55.2140,0002,208,5001,161,250Nov 05 07:56 PM
NEWTON ROGER SDirectorNov 02Sale50.7622711,523573,726Nov 02 05:00 PM
NEWTON ROGER SDirectorNov 01Sale50.012,600130,026573,953Nov 02 05:00 PM
NEWTON ROGER SDirectorOct 18Sale50.001005,000576,553Oct 18 05:05 PM
HNNA Hennessy Advisors, Inc. daily Stock Chart
HNNA [NASD]
Hennessy Advisors, Inc.
Index- P/E8.41 EPS (ttm)1.33 Insider Own43.70% Shs Outstand7.38M Perf Week-0.44%
Market Cap82.21M Forward P/E7.79 EPS next Y1.43 Insider Trans-0.12% Shs Float4.29M Perf Month8.29%
Income12.30M PEG- EPS next Q0.41 Inst Own11.80% Short Float2.57% Perf Quarter12.63%
Sales45.70M P/S1.80 EPS this Y62.50% Inst Trans- Short Ratio7.75 Perf Half Y17.14%
Book/sh3.09 P/B3.61 EPS next Y-5.30% ROA11.20% Target Price13.25 Perf Year-18.21%
Cash/sh3.21 P/C3.47 EPS next 5Y- ROE16.60% 52W Range9.00 - 13.90 Perf YTD11.29%
Dividend0.55 P/FCF6.09 EPS past 5Y41.30% ROI27.70% 52W High-19.86% Beta0.89
Dividend %4.94% Quick Ratio2.90 Sales past 5Y17.60% Gross Margin79.00% 52W Low23.78% ATR0.45
Employees20 Current Ratio2.90 Sales Q/Q-23.50% Oper. Margin39.80% RSI (14)60.86 Volatility2.85% 4.33%
OptionableNo Debt/Eq0.25 EPS Q/Q10.00% Profit Margin26.80% Rel Volume1.30 Prev Close11.14
ShortableYes LT Debt/Eq0.19 EarningsNov 06 AMC Payout32.30% Avg Volume14.24K Price11.14
Recom- SMA203.32% SMA508.78% SMA20011.07% Volume0 Change0.00%
Sep-30-19 07:23PM  IMEA Honors Hennessy Funds for "Best Overall Advisor Communications" for Third Consecutive Year PR Newswire
Aug-07-19 05:30PM  Hennessy Advisors, Inc. Reports Third Quarter Earnings PR Newswire
May-16-19 05:53PM  Hennessy Advisors, Inc. Repurchases Shares PR Newswire
May-07-19 07:32PM  Hennessy Advisors: Fiscal 2Q Earnings Snapshot Associated Press
04:15PM  Hennessy Advisors, Inc. Reports Second Quarter Earnings of $0.37 Per Share PR Newswire
Apr-04-19 12:58PM  Hennessy Japan Small Cap Fund Buys 6 Stocks in 1st Quarter GuruFocus.com
11:54AM  Hennessy Japan Fund Invests in Pet Insurance Company Anicom GuruFocus.com
Mar-08-19 06:00AM  Hennessy Japan Small Cap Fund Named 2019 Lipper Fund Award Winner PR Newswire
Feb-12-19 06:05PM  Hennessy Advisors: Fiscal 1Q Earnings Snapshot Associated Press
04:15PM  Hennessy Advisors, Inc. Reports First Quarter Earnings of $0.39 Per Share PR Newswire
Jan-25-19 05:20PM  Peter Lynch Screens Identify Opportunities for 2019 GuruFocus.com
Dec-10-18 04:49PM  Your love of index funds is terrible for our economy MarketWatch
Nov-28-18 04:15PM  Hennessy Advisors, Inc. Reports Increases in Annual Revenue, Earnings, and Net Income PR Newswire -5.34%
Nov-15-18 08:25AM  New Research Coverage Highlights CommVault, Dawson Geophysical, RF Industries, Hennessy Advisors, VIVUS, and Semiconductor Manufacturing International Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-30-18 04:15PM  Hennessy Advisors, Inc. Increases Dividend 10% PR Newswire
Oct-26-18 06:15PM  Hennessy Advisors, Inc. Acquires the BP Capital TwinLine Funds, Completing Its Tenth Asset Purchase PR Newswire
Oct-12-18 01:51PM  IMEA Honors Hennessy Funds for "Best Overall Advisor Communications" PR Newswire
Sep-05-18 01:22PM  [$$] 3 Cheap Stocks From an Unrepentant Active Manager Barrons.com
Aug-01-18 06:35PM  Hennessy Advisors: Fiscal 3Q Earnings Snapshot Associated Press
04:15PM  Hennessy Advisors, Inc. Reports Third Quarter Earnings of $0.53 Per Share PR Newswire
Jul-10-18 04:15PM  Hennessy Advisors, Inc. to Acquire the BP Capital TwinLine Funds PR Newswire
Jun-25-18 03:15PM  Is Hennessy Advisors Incs (NASDAQ:HNNA) PE Ratio A Signal To Buy For Investors? Simply Wall St.
Jun-20-18 02:05PM  Hennessy Advisors Inc (NASDAQ:HNNA): A Fundamentally Attractive Investment Simply Wall St.
Jun-14-18 01:02PM  Cheap Financial Stocks This Week Simply Wall St.
Jun-01-18 07:30PM  Is Hennessy Advisors Inc (NASDAQ:HNNA) A Great Dividend Stock? Simply Wall St.
May-25-18 04:07PM  Neil Hennessy Sees a Lot of Investment Opportunities...If You're Patient Bloomberg Video
04:07PM  Neil Hennessy Sees a Lot of Investment Opportunities...If You're Patient Bloomberg
May-10-18 01:02PM  Top 3 Undervalued Financial Stocks For The Month Simply Wall St.
May-02-18 07:59PM  Hennessy Advisors: Fiscal 2Q Earnings Snapshot Associated Press
04:15PM  Hennessy Advisors, Inc. Reports Second Quarter Earnings of $0.58 Per Share PR Newswire
Apr-24-18 08:02PM  Who Really Owns Hennessy Advisors Inc (NASDAQ:HNNA)? Simply Wall St.
Apr-16-18 08:10PM  Does Hennessy Advisors Inc (NASDAQ:HNNA) Go Up With The Market? Simply Wall St.
Mar-30-18 03:19PM  Should You Be Tempted To Buy Hennessy Advisors Inc (NASDAQ:HNNA) Because Of Its PE Ratio? Simply Wall St.
Mar-13-18 03:26PM  Interested In Hennessy Advisors Inc (NASDAQ:HNNA)? Heres What Its Recent Performance Looks Like Simply Wall St.
Mar-02-18 10:35AM  How Does Hennessy Advisors Inc (NASDAQ:HNNA) Fare As A Dividend Stock? Simply Wall St.
Feb-28-18 03:49PM  Hennessy Funds Named 2018 Lipper Fund Award Winner PR Newswire
Feb-04-18 08:39AM  Hennessy Advisors Inc (NASDAQ:HNNA): Dividend Is Coming In 3 Days, Should You Buy? Simply Wall St.
Jan-26-18 09:00AM  Teresa M. Nilsen Appointed President of Hennessy Advisors, Inc. PR Newswire
Jan-25-18 05:35PM  Hennessy Advisors posts 1Q profit Associated Press
04:15PM  Hennessy Advisors, Inc. Reports First Quarter Earnings of $1.04 Per Share PR Newswire
Jan-12-18 06:31PM  Hennessy Advisors, Inc. Completes the Acquisition of the Rainier U.S. Equity Funds, Bringing Assets Under Management to $7.3 Billion PR Newswire
Dec-29-17 12:07PM  ETFs with exposure to Hennessy Advisors, Inc. : December 29, 2017 Capital Cube
07:50AM  Blog Exposure KKR to Acquire PetVet Care Centers ACCESSWIRE
Dec-18-17 03:40PM  ETFs with exposure to Hennessy Advisors, Inc. : December 18, 2017 Capital Cube
Dec-12-17 09:42AM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: Q4, 2017 By the Numbers : December 12, 2017 Capital Cube
Dec-07-17 02:00PM  ETFs with exposure to Hennessy Advisors, Inc. : December 7, 2017 Capital Cube
Dec-06-17 10:42AM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: 2017 By the Numbers : December 6, 2017 Capital Cube
Dec-04-17 04:15PM  Hennessy Advisors, Inc. Reports Record Annual Earnings and Revenue PR Newswire
Dec-01-17 06:42PM  Hennessy Advisors, Inc. Acquires Two Rainier U.S. Equity Funds PR Newswire
Nov-14-17 01:21PM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : November 15th, 2017 (record date) : By the numbers : November 14, 2017 Capital Cube
Nov-01-17 08:46PM  Hennessy Funds Receives Six 2017 MFEA STAR Awards, Including Best Overall Advisor Communications PR Newswire
Oct-31-17 04:15PM  Hennessy Advisors, Inc. Announces Quarterly Dividend PR Newswire
Oct-25-17 10:00AM  ETFs with exposure to Hennessy Advisors, Inc. : October 25, 2017 Capital Cube
Oct-10-17 11:31AM  ETFs with exposure to Hennessy Advisors, Inc. : October 10, 2017 Capital Cube
Oct-02-17 08:56AM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: Q3, 2017 By the Numbers : October 2, 2017 Capital Cube
Sep-15-17 02:39PM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : August 17th, 2017 (record date) : By the numbers : September 15, 2017 Capital Cube
Aug-03-17 01:07AM  Hennessy Advisors posts 3Q profit Associated Press
Aug-02-17 04:15PM  Hennessy Advisors, Inc. Reports Third Quarter Earnings of $0.51 Per Share; Firm Also Announces Quarterly Dividend PR Newswire
May-12-17 01:46PM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : May 16th, 2017 (record date) : By the numbers : May 12, 2017 Capital Cube
May-11-17 04:15PM  Hennessy Advisors, Inc. to Acquire the Rainier U.S. Equity Funds PR Newswire
May-04-17 04:01PM  ETFs with exposure to Hennessy Advisors, Inc. : May 4, 2017 Capital Cube
May-03-17 10:15AM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: Q2, 2017 By the Numbers : May 3, 2017 Capital Cube
May-01-17 05:12PM  Hennessy Advisors posts 2Q profit Associated Press
04:15PM  Hennessy Advisors, Inc. Reports Second Quarter Earnings Per Share Increase of 9%; Firm Also Announces Quarterly Dividend PR Newswire
Mar-24-17 03:03PM  Hennessy Funds Named 2017 Lipper Fund Award Winner PR Newswire
Mar-22-17 11:47AM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : February 10th, 2017 (record date) : By the numbers : March 22, 2017 Capital Cube
11:47AM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : February 10th, 2017 (record date) : By the numbers : March 22, 2017
Mar-07-17 04:27PM  HENNESSY ADVISORS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
Mar-06-17 07:03AM  Splits Calendar: Hennessy Advisors splits before market open today (3:2 ratio)
Feb-02-17 01:38PM  ETFs with exposure to Hennessy Advisors, Inc. : February 2, 2017 Capital Cube
01:38PM  ETFs with exposure to Hennessy Advisors, Inc. : February 2, 2017
Feb-01-17 01:04PM  HENNESSY ADVISORS INC Financials
Jan-31-17 12:27PM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: Q1, 2017 By the Numbers : January 31, 2017 Capital Cube
12:27PM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: Q1, 2017 By the Numbers : January 31, 2017
Jan-30-17 04:10PM  HENNESSY ADVISORS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jan-27-17 02:08PM  HENNESSY ADVISORS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-26-17 07:30PM  Hennessy Advisors, Inc. Announces 3-for-2 Stock Split and Quarterly Dividend Increase of 12.5% PR Newswire
05:29PM  HENNESSY ADVISORS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
05:12PM  Hennessy Advisors posts 1Q profit Associated Press
05:02PM  Hennessy Advisors, Inc. Reports First Quarter Earnings Increase of 4% PR Newswire
04:59PM  HENNESSY ADVISORS INC Files SEC form 10-Q, Quarterly Report
Jan-12-17 01:12PM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : November 15th, 2016 (record date) : By the numbers : January 12, 2017 Capital Cube
01:12PM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : November 15th, 2016 (record date) : By the numbers : January 12, 2017
Dec-19-16 11:45AM  ETFs with exposure to Hennessy Advisors, Inc. : December 19, 2016 Capital Cube
11:45AM  ETFs with exposure to Hennessy Advisors, Inc. : December 19, 2016
Dec-16-16 08:11AM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: 2016 By the Numbers : December 16, 2016
Dec-01-16 04:21PM  HENNESSY ADVISORS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:20PM  Hennessy Advisors, Inc. Reports Record High Annual Earnings and Revenue PR Newswire
Oct-31-16 04:49PM  HENNESSY ADVISORS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:45PM  Hennessy Advisors, Inc. Increases Dividend by 25% PR Newswire
Oct-24-16 07:19PM  Hennessy Funds Receives Seven 2016 MFEA STAR Awards PR Newswire
Oct-19-16 02:20PM  Hennessy Advisors, Inc. : HNNA-US: Dividend Analysis : August 18th, 2016 (record date) : By the numbers : October 19, 2016
Oct-13-16 04:18PM  HENNESSY ADVISORS INC Files SEC form 8-K, Change in Directors or Principal Officers
Sep-23-16 04:48PM  HENNESSY ADVISORS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Di
04:45PM  Hennessy Advisors, Inc. Acquires The Westport Funds Bringing Assets Under Management to $6.8 Billion PR Newswire
Sep-09-16 10:53AM  ETFs with exposure to Hennessy Advisors, Inc. : September 9, 2016
Sep-08-16 02:00PM  3 Small Stocks that Insiders Are Selling
Aug-15-16 01:30PM  Hennessy Advisors, Inc. :HNNA-US: Earnings Analysis: Q3, 2016 By the Numbers : August 15, 2016
Aug-03-16 04:43PM  Hennessy Advisors posts 3Q profit
04:21PM  HENNESSY ADVISORS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi
Hennessy Advisors, Inc. is publicly owned investment manager. It provides its services to Hennessy Funds and investment companies. The firm launches and manages equity, fixed income, and balanced mutual funds. It invests in the public equity and fixed income markets across the globe. The firm primarily invests in growth stocks of companies. It conducts in-house research to make its investments. Hennessy Advisors, Inc. was founded in 1989 and is based in Novato, California with additional offices in Boston, Massachusetts and Chapel Hill, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NILSEN TERESA MPresident, COO and SecretarySep 19Sale10.071,50015,104146,667Sep 19 05:13 PM
NILSEN TERESA MPresident, COO and SecretarySep 18Sale10.202,50025,501148,167Sep 19 05:13 PM